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This Royal Pharmaceutical Society discussion paper is a valuable 
addition to the thinking on shared decision-making. Professor Alan 
Cribb makes a nuanced and considered argument for shared 
decision-making, which shares common themes with the Royal 
College of Physicians’ own work on improving communication 
and understanding between patients and clinicians. His analysis 
of the potential practical and ethical issues that need to be 
addressed to enable the successful implementation of shared 
decision-making will be of strong interest to medical professionals.
Dr Linda Patterson
Clinical Vice President
Royal College of Physicians
Patient-centred care and shared decision-making between 
patients and healthcare professionals has been a dominant 
theme of health policy for many years now. Despite wide 
acceptance of increased patient involvement as best 
practice there remains a significant gap between policy 
ideal and the reality on the ground. The need to bridge 
this gap has become more apparent with the current 
government placing patient involvement firmly at the 
centre of health policy.
Professor Alan Cribb’s timely discussion paper explores the 
inherent complexities of increasing patient involvement in 
treatment decisions, looking through the lens of prescribed 
medicines and their use. These complexities resonate 
strongly with the pharmacy profession; the experts in 
medicines and their use. The practical and ethical dilemmas 
involved in increasing patient involvement in medicines use 
present themselves daily to patient-facing pharmacists. 
Alan, in acknowledging that “guidelines can help inform, 
but they cannot replace context-responsive professional 
judgement”, highlights the challenge of supporting 
healthcare professionals in exercising their professional 
judgement.
The Royal Pharmaceutical Society recognises the 
complexities of patient-centred care and will continue 
to support pharmacists in exercising their professional 
judgement. We also recognise and welcome Alan’s 
considerable scholarship in the area of patient involvement 
and shared decision-making and have heard the mandate 
to champion educational change and support greater 
collegial, multidisciplinary leadership for the benefit of 
patients and the public.
Martin Astbury FRPharmS    
President     
Royal Pharmaceutical Society
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The Health Foundation is delighted to welcome this paper, a rare 
animal in that it is both practical and erudite. It is an important 
contribution, revealing the realities and challenges that will inevitably 
face health systems as we forge a new set of relationships between 
patients and clinicians. As Professor Cribb argues, it is right and 
inevitable that we move to a world in which patients are “worked 
with, rather than worked on”; but eliminating the current policy-
practice gap around involvement requires the sort of intelligent, 
sophisticated analysis and treatment that this paper provides. 
It is all too easy to use words such as shared decision-making, 
patient-centred care and partnership; and there is no shortage 
of such rhetoric within the current health policy context in the 
UK. Like Professor Cribb, The Health Foundation welcomes and 
supports the growing emphasis on this long-neglected driver of 
quality in healthcare. Indeed, we have been amongst those pushing 
this agenda. However, we too appreciate that the crude fudging of 
terminology around involvement by politicians is an impediment 
to progress; and we too believe that achieving real partnership is 
not only a question of attitude and desire, or even strategy, but 
also requires subtle, sophisticated execution: what this paper calls 
“stepping stones” to change.
It is precisely this need for greater practical learning about what is 
required to support professionals with this journey that has led the 
Health Foundation to invest in two demonstration programmes 
focused on implementation: Co-creating Health and Magic. We are 
delighted that through his research, Professor Cribb came across 
Co-creating Health and appreciate his warm endorsement of the 
Co-creating Health approach within this paper. 
It may not have been Professor Cribb’s initial intention, but I suspect 
that reading this paper will greatly increase readers’ empathy with 
the complex position in which professionals now find themselves. 
That is not, however, to say that it is a reactionary defence of 
professionals. Rather, it is a call for us to fully understand and address 
the genuine constraints and concerns that limit the rate at which 
they can change. Professor Cribb describes the legitimate concerns 
on the part of professionals about what it means in practice to 
shift clinical approach in line with the growing shift away from 
traditional paternalism. This paper clearly illustrates the genuine 
dilemmas – about risk, patient safety, the professional’s own risk 
management – which constrain professionals’ ability to take on 
these practices. Through our experience with Co-creating Health, 
working with over a thousand health professionals across the UK, 
we have seen that the transition to adopting greater involvement 
practices by clinicians is an incremental process – a journey over 
time of integrating new forms of consultation and communication 
into long-established habits. 
Traditionally, professionalism has been seen as a quality of the 
individual clinician – as opposed to the relationship-based approach 
that Professor Cribb takes within this report and which The Health 
Foundation too supports. Relationships with patients, alongside 
relationships with other health professionals and relationships with 
the health system, are the qualities that we now understand make 
up modern professionalism. 
The paper calls for a reduction in the “emphasis on abstract models 
and labels” and an increase in “our attention to the practical and 
philosophical complications that have to be negotiated in day to 
day clinical work”. One of these practical complications is that 
health professionals do not practice in isolation or in the abstract, 
but rather, within the highly complex systems that characterise 
modern healthcare. The other joy of this paper is its recognition of 
the critical place of context and conditions on the capacity of the 
individual to change. This integration of systems-thinking, alongside 
the insights from philosophy that Professor Cribb brings to this 
paper, point the way towards the methods and techniques that will 
work on the ground to support change. 
Finally, thanks are due to the Royal Pharmaceutical Society and the 
Arts and Humanities Research Council for their support for this 
paper. It could not come at a more important time. The Health 
and Social Care Bill currently making its way through Parliament 
in Westminster enshrines patients’ rights to a high degree of 
involvement in their own healthcare. The Bill has had a challenging 
time in Parliament, but this will be as nothing relative to the 
challenges of its implementation. North of the border, in Scotland, 
the national Quality Strategy has “mutuality” at its heart – a similar 
but different term posing further questions for the professionals 
required to deliver it. We need as much help as we can get to 
move to the new world of healthcare to which we all strive, and 
this paper is a big help. I am delighted to commend it. 
Natalie Grazin
Assistant Director
Health Foundation
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INVOLVEMENT, SHARED DECISION-MAKING 
AND MEDICINES
This discussion paper builds on the deservedly influential 
work of the Royal Pharmaceutical Society on concordance. 
It is concerned with putting concordance into context 
in two senses. First, it discusses the importance of 
concordance (or what is known more generally as shared 
decision-making) as part of a wider family of ‘involvement’ 
concerns; and second, it explores the challenge of applying 
ideas about, or models of, involvement in the real and 
very diverse contexts of professional practice. This paper 
also has some strong resonances with the very recent 
report and recommendations of the Royal College of 
Physicians on Why people matter in medicines. The authors 
of that report stress the importance of partnership not 
only between professionals and patients but also between 
groups of health professionals, writing that, ‘[w]e cannot 
emphasise enough the need for collaboration between 
health professionals and between doctors and pharmacists’ 
(2011, p3). These forms of collaboration are not the focus 
of this discussion paper, but it is hoped that, nonetheless, 
the changes it calls for may also play a small part in 
encouraging such professional partnerships.
Executive Summary
The central argument of this paper can be summarised    
as follows:
1. There is increasingly a new policy orthodoxy that: 
  more partnership working between clinicians and 
patients is fundamentally important and, in particular, 
that shared decision-making about treatment choices is 
needed for reasons of both effectiveness and ethics;
  despite many efforts there is a big gap to close 
between these general ideals and routine practice;
  further steps need to be taken to close this gap.
2. The new policy orthodoxy is to be welcomed. However 
it is also important to recognise that not all of the gap 
between ideals and practice should be seen as mere 
‘resistance’ or ‘drag’ on the part of healthcare professionals. 
In particular :
  the right infrastructure and tools need to be put in 
place if calls for widespread partnership working are to 
be realistic;
  some of the gap between ideals and practice stems 
from valid concerns and from the inherent complexities 
of involvement- or partnership-related values. 
3. Policy attempts to ‘push’ the involvement agenda – 
including the implementation of ideas such as concordance 
or shared decision-making – will not succeed, and may 
even be counter-productive, unless the practical and ethical 
challenges and dilemmas surrounding this agenda are 
explicitly addressed and fully reflected in policy initiatives 
and practice development.
The report aims to make a contribution to addressing 
these challenges and to formulating more realistic (i.e. 
context-sensitive and practicable) policy. It draws upon 
conversations and interviews with professionals and on 
academic work in applied philosophy (summaries of which 
are presented in two appendices), as well as on the existing 
literature on involvement and shared decision-making. Each 
of these three sources highlights important shortcomings 
behind well meaning but simple ‘policy solutions’ in this 
area. In particular both the experience of professionals and 
philosophical analysis show that, in addition to significant 
practical and infrastructural challenges, there are dilemmas 
inherent in models of shared decision-making which need 
to be recognised as part of effective implementation. 
Similarly, academic proponents of shared decision-making 
are often advocating a much more subtle and internally 
complex approach than the one reflected in policy. A 
crucial insight from this work is that narrow ‘technicist’ 
models – either in the construction or the implementation 
of approaches such as shared decision-making will not 
work and may even be counter-productive.
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Key conclusions are:
1. Progress depends upon achieving greater clarity about 
the range of different purposes and agendas being pursued 
in the area of medicines and patient involvement. Fudging 
these different purposes and agendas together under single 
headings such as ‘shared decision-making’ (or ‘choice’) is 
often unhelpful and masks the diversity of approaches 
needed to tailor involvement to specific circumstances and 
cases and to address practice dilemmas. 
2. The gap between policy ideals and routine practice can 
only be narrowed if both policy and practice are reformed. 
In particular :
  Educational change and collegial leadership are 
needed to underpin new, more responsive, models of 
professionalism and to encourage the ‘practical wisdom’ 
that is the essential component of professionalism. 
  If new models of working are to be feasible, 
infrastructural ‘stepping stones’ need to be identified 
and put in place. In so doing, the important and 
carefully researched traditions of practice development 
that already exist in this area need to be drawn upon 
and built upon.
  It is also necessary to prompt ‘systems re-thinking’ 
and systemic changes in health services, but there is 
a circumscribed role for managerial, ‘incentive based’ 
or other ‘technicist’ interventions in this area. Similarly, 
arguments from cost-effectiveness can play a role – in 
addition to the central arguments about care quality 
and ethics – but arguments based upon cost savings 
should be used carefully.
3. Policy in this area must maintain the strongly reformist, 
even transformative, zeal of the advocates of patient 
involvement and shared decision-making. But this zeal 
needs to be combined with: (i) a carefully differentiated 
account of the nature and values of involvement; and      
(ii) an approach to change that supports and protects 
these values.
Overall the paper is designed to map and clarify the various 
purposes and agendas at stake in patient involvement 
policies in relation to medicines, and the practical and 
ethical challenges of translating these purposes into 
practice. The appendices are designed not only to help 
illuminate and support the content of the paper but also to 
inform educational developments in this area.
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1. BACKGROUND
Over the past three decades, the notion that ‘patients’, ‘lay 
people’ or ‘the public’1 should be ‘involved’ in healthcare 
provision has become increasingly prominent and influential. 
It is no exaggeration to say that patient involvement is 
now established as ‘policy orthodoxy’, and it has even been 
described as a ‘policy imperative’ (Thompson, 2007). Patient 
involvement is unquestionably a very important agenda for 
health policy and healthcare professional practice but – as 
the continual emphasis and re-emphasis on the need for 
reform in the area also indicates - it is also an extremely 
challenging agenda. The main sections of this discussion 
paper analyse some of the difficulties of translating 
involvement ideals into routine practice and consider some 
possible ways forward. To begin with, however, this section 
will provide a little more background - underlining the 
strength of the new policy orthodoxy, and introducing the 
importance, and some of the complexity, of the idea of 
involvement and the relevance of this theme to the broad 
area of prescribing and medicines use.
The new policy orthodoxy
This discussion paper focuses on issues related to 
the involvement of individual patients in prescribing 
decisions and the use of prescribed medicines. However, 
it is important to recognise that ideas about this have 
developed alongside thinking about both the involvement 
of individuals in their own healthcare more generally2 and 
about the involvement of patients or (potential) service 
users collectively.3 Over recent years many overlapping 
policy labels have been used to capture and promote these 
ideas: as well as patient and public involvement we have, 
for example, had talk of patient-centredness or person-
centredness, personalisation, partnership and shared 
decision-making. 
These involvement-related concerns, and the broader 
discourses behind them, have been in mainstream 
circulation for at least thirty years. They were deeply 
embedded in official government policies throughout the 
‘New Labour’ era and have been equally prominent in the 
policy climate of the Coalition government formed in 2010. 
Indeed, if anything, this policy emphasis is being intensified.4 
Both in the first health White Paper of the Coalition era 
(DoH, 2010) and in associated speeches by the Secretary 
of State for Health the importance of patient involvement, 
and, in particular, the language of shared decision-making, 
were placed at the centre of health policy, and represented 
as the ‘first principle’ of the new NHS:
“Many of you will already treat your patients as partners. 
Involving them in decisions, giving them as much choice as 
is possible within the bounds of appropriate treatment. This 
should be the case for everyone.”
Secretary of State for Health’s speech to the National 
Association of Primary Care’s annual conference,             
21 October 2010
1 There is, notoriously, no single satisfactory term to use here. Each term has advantages and disadvantages, and the use of ‘patients’ most of the 
time in what follows is purely for reasons of simplicity and does not detract from these complications.
2 For example, by their ‘speaking up’ about threats to their safety in healthcare contexts and by a growing emphasis on self-management and 
healthy lifestyles more widely.
3 For example, in the governance of health professionals, the licensing and regulation of medicines, and the planning, organisation and evaluation 
of services.
4 The very short policy summary provided here relates primarily to England. There are of course significantly different policy settlements in the 
countries of the UK. However, most of the diversity is arguably connected to different structural and ideological emphases in the organisation of 
health services rather than to differing conceptions of healthcare professionalism. Indeed the shift towards the greater involvement of patients 
in clinical decision-making, including partnership models of professional-patient working, is part of a very long-term and international trend in 
healthcare. One recent example of the spread of discourses of shared decision-making can be seen, for example, in the statement produced by  
the Salzburg Global Seminar (2011): 
see press.psprings.co.uk/bmj/march/SalzburgStatement.pdf. 
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“For the NHS, through the White Paper, we set out those 
principles: first, a patient-centred NHS. Patients not just as 
beneficiaries of care, but as active partners in its design 
and delivery. Shared decision-making. Patients feeling that 
invariably, when they encounter the health service, it’s a case 
of ‘no decision about me, without me.’”
Secretary of State for Health’s speech to the  
National Clinical Assessment Service conference,   
5 November 2010
This stress on decision-making partnerships is explicitly 
retained in the government’s more recent response   
to the ‘listening exercise’ and the Future Forum report   
in particular :
“Our White paper declaration, ‘no decision about me without 
me’ aspires to an NHS where patients are involved fully 
in their own care, with decisions made in partnership with 
clinicians, rather than by clinicians alone.”
“[S]hared decision-making must become the norm and 
not the exception. As suggested by the Future Forum, we 
will amend commissioners’ duties to involve patients and 
carers in their own care to better reflect the principle of ‘no 
decision about me without me.’” (Original emphasis.)
Government response to the NHS Future Forum report 
(Department of Health, June 2011, p39)
In addition to government and government agencies, 
other influential health policy bodies have helped to clarify 
and champion the importance of patient involvement. 
For example, the Picker Institute, the Royal College of 
Physicians and the King’s Fund have contributed important 
work on new models of clinical professionalism that 
stress the need for ‘patient-oriented’ working and patient-
professional partnerships (Askham & Chisholm, 2006; 
Levenson, Dewar, & Shepherd, 2008; RCP, 2005). 
In the area of medicines and patient involvement the 
landmark work on developing and disseminating the notion 
of ‘concordance’ – partnership working in prescribing and 
medicines taking – stems from the RPSGB report of 1997 
(Royal Pharmaceutical Society of Great Britain, 1997). 
But this current of work on medicines and concordance 
has continued through the activities of other agencies, 
especially the Medicines Partnership and the National 
Prescribing Centre (Cox, Stevenson, Britten, & Dundar, 
2004; Clyne, Granby, & Picton, 2007) and has been usefully 
explicated in recent books (Bond, 2004; Dowell, Williams, 
& Snadden, 2007). This current directly fed into the 2009 
National Institute for Health and Clinical Excellence (NICE) 
guidelines on ‘Medicines Adherence’ (NICE, 2009; Nunes 
et al., 2009). These guidelines represent a recent milestone 
in medicines policy making because they give an official 
articulation and endorsement of the crucial importance 
of patient involvement in medicines decision-making. The 
expectation endorsed and reinforced by the guidelines is, 
once again, that patients should be seen less as ‘passive’ and 
more as ‘partners’ in prescribing as well as medicines taking. 
(These guidelines are discussed further in section 3).
What is involvement? Why does it 
matter? Why medicines?
The question ‘What is involvement?’ is more difficult to 
answer than might be first thought and much of this 
discussion paper is given over to illustrating the complexity 
of involvement. However, before going any further it is 
worth offering a summary answer to it. Some notion of 
what patient involvement means is obviously indicated 
by the discussion thus far ; i.e. it indicates relatively active 
rather than passive patients or service users, and thereby 
something like a partnership between professionals and lay 
people – patients being ‘worked with’ rather than simply 
‘worked on’. However, beyond this very broad sketch, the 
notion of patient involvement is a highly complex one (as is 
also indicated by the different kinds of labels and languages 
associated with it and referred to above).
Patient involvement can be seen as an umbrella category 
that covers a diverse range of possibilities, emphases, 
models and practices. To begin to open up this diversity  
it is worth spelling out two sets of basic distinctions alluded 
to above, distinctions between: individual and collective 
forms of involvement; and the involvement of patients in 
clinical practices and their involvement in broader health-
related practices. 
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These distinctions are not entirely sharp or clear-cut. For 
example, collective involvement can help shape the terms 
of individual involvement: if patients participate in a group 
– perhaps representing their perspectives on conditions 
and treatments, and advising on, or advocating for, service 
reform – then they can help shape the participation 
opportunities open to themselves as individual service 
users. Similarly the distinction between a clinical practice 
and a health-related practice is not a clear-cut one. 
Roughly speaking, we can stipulate that clinical practices 
are those that have traditionally been regarded as falling 
within the domain, and responsibility, of clinicians and other 
professionals (for example, diagnosis, treatment and referral 
judgements at an individual level, and service planning, 
management, audit etc. at a collective level); and we can 
stipulate that health-related practices are those that have 
traditionally been regarded as falling within the domain, 
and responsibility, of patients or citizens (for example, 
treatment adherence and lifestyle practices at an individual 
level and lobbying, campaigning etc. at a collective level). But 
these boundaries are neither clear nor fixed. The familiar 
example of someone choosing to buy certain medicines 
over the counter rather than seeking a consultation and a 
prescription for the same medicines illustrates this, as does 
the fact that a number of medicines have been reclassified 
so that they are no longer prescription-only but are 
available over the counter. Equally, if someone is prescribed 
some medication to take in the 24 hours running up to 
an operation, then adherence to this medication seems to 
count both as involvement in a clinical practice and as one 
of the health-related practices of the patient.
These rough distinctions generate four broad possibilities
Examples of these possibilities are:
A.  An individual patient playing some active role in his or   
 her treatment decisions within clinical consultations.
B.  An individual patient attending a health promotion or   
 self-management course.
C.  Service users participating in service planning activities.
D.  A patient organisation lobbying for public policy change.
The main emphasis of this discussion paper is on ‘category 
A’ forms of involvement. But, as has just been noted, this 
needs to be seen in the broader context of the other three 
sets of possibilities.
This simple - A to D - taxonomy also indicates that as well 
as patient involvement in clinical practices (A and C) there 
is also the need for what might be thought of as ‘clinical 
involvement’ in patients’ broader health-related practices 
(B and D); i.e. in addition to fulfilling their own clinical role, 
clinicians (and other professionals and services) can help 
foster, support and participate in people’s health-related 
practices. Involvement might thus be seen as allowing for 
the possibility of a ‘two way’ movement. Just as the patient 
can enter into, and somehow participate in, the clinical 
sphere, clinicians can enter into, and participate in, the ‘non-
clinical’ sphere; i.e. the lives, life circumstances and lifeworlds 
of patients. Recognising the potential for this ‘two way’ 
movement is important. If our focus is on something like 
partnership working, then this entails potential adjustments 
and accommodations for everyone. This ‘two way’ idea is to 
some extent embedded in the work on concordance by 
the stress that is placed both on clinicians including patients 
in prescribing decisions and on clinicians supporting patients 
in medicines use.
The contemporary emphasis on involvement is 
underpinned by two fundamental and linked concerns. 
The first is a concern with effectiveness: involving 
people in decisions about the medicines they will be 
prescribed, for example, has the potential to improve their 
understanding, medicines use, health and satisfaction. The 
second is a concern with ethics: if service provision, either 
at an individual or a collective level, is to be legitimate 
and properly respectful of patients then it ought to be 
responsive to and reflect the perspectives and values 
of patients. In short, involvement can be seen as both 
practically useful and as intrinsically worthwhile. Lying 
behind the ‘policy imperative’ of involvement, therefore, is 
what can be thought of as both a ‘quality imperative’ and 
an ‘ethical imperative’. Linked with these things, but more 
contentiously, there are sometime allusions to what might 
be called an ‘economic imperative’, i.e. the thought that 
health resources are likely to be used more cost effectively 
and allocated more efficiently if patients are involved in 
their choice of treatment - both because they may resist 
In clinical practices In broader 
healthcare practices
Individual 
involvement A B
Collective 
involvement C D
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accepting (sometimes distressing or otherwise demanding) 
treatments when these treatments have unclear benefits 
and because they are more likely to participate effectively 
in treatments that are actively agreed to because these 
treatments feel ‘chosen’ rather than ‘imposed’. These core 
ideas - that involvement produces higher standards   
(in healthcare quality and ethics) and potentially also 
improves cost-effectiveness – were cited in the Secretary 
of State for Health’s speech to the National Association of 
Primary Care, referred to above:
“There is a vast amount of research that clearly 
demonstrated what every one of you will know instinctively. 
That a patient’s treatment is always better and often 
cheaper when they are more than just a passive recipient of 
care, but an active participant in it.”
Is there any particular reason to focus on involvement in 
relation to medicines, rather than the many other areas of 
healthcare? In one sense medicines can be seen simply as 
one very important example of a healthcare intervention. 
But medicines are also a particularly useful example 
because, as noted above, they sit at the interface of clinical 
practices and health practices; i.e. they operate between 
the clinical and the personal realms. In other words, 
medicines are very often clinical interventions in people’s 
lives but the operationalisation of these interventions 
typically depends upon the active participation of these 
people. It is for this reason that ‘adherence’ (and related 
ideas such as concordance) has become such an important 
focus of concern and research. 
Medicines thus provide one particularly valuable 
lens through which to view the challenges of patient 
involvement. At the same time it is worth noting there are 
some relatively distinctive challenges facing involvement 
policy in the area of prescribed medicines which can be 
summarised here in four broad points. Although these 
points are certainly not unique to medicines, taken in 
combination, they apply especially to medicines: 
(i) medicines are typically self-administered and managed, 
sometimes over long periods of time in which patients 
move through different service settings, illness phases 
and life phases; (ii) the mechanisms by which medicines 
work are, for the most part, extremely technical and hard 
to explain; (iii) knowledge about medicines (specifically, 
different kinds and uses of medicines) is very unequally 
shared by the various health professionals who may 
be called upon to discuss medicines with patients; (iv) 
knowledge about the likely positive and negative effects of 
medicines is largely population based and sometimes very 
difficult to apply to individuals. To some extent this can 
be overcome by adopting ‘trial and error’ approaches to 
prescribing, which frequently have an important role to play 
in matching medicines to patients, but these in turn depend 
on managing information across service settings and also 
pose their own problems for managing involvement. In 
summary, medicines-related involvement is a very useful 
area to analyse but, of course, we should be wary of 
automatically extrapolating such analyses to other areas. 
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2. UNDERSTANDING THE POLICY-
PRACTICE GAP
The gap between policy orthodoxy and routine practice is 
well known and persistent. For example, the data that the 
Picker Institute collect from hospitals continue to show that, 
although there are some promising signs of improvement 
in some domains, patients do not feel as involved in their 
treatment as they would like to be and do not get as 
much information about their medicines as they would 
like to have (Richards & Coulter, 2007; Sizmour & Redding, 
2010). There is also a wealth of research that shows that 
concordant approaches to prescribing are not routinely in 
place (Cox et al., 2004; Horne et al., 2005). 
One reading of this gap rests upon a – sometimes explicit 
but often implicit – deficit picture of health professionals. 
According to this reading, professionals are simply not 
willing or able to move away from a traditional paternalistic 
approach to treatment in which their own expertise and 
professional judgement is centre stage and the job of 
patients is essentially to co-operate or even to ‘comply’ 
with these professional judgements. This deficit story is 
most often ascribed to doctors but can also be ascribed 
to other health professionals, and, in more explicitly critical 
accounts, is seen as simply a function of professional power 
and of practices that preserve and protect professional 
power. (There are also, of course, deficit pictures of 
patients that are sometimes used to explain the gap.)
It would take a foolish person to argue that this deficit 
reading of professionals is a total irrelevance, based upon a 
complete misreading of reality. Nonetheless, there is a real 
danger that too much emphasis is placed upon this reading 
and that it effectively acts as a smokescreen that prevents 
us from confronting the full range of factors that explain 
the policy-practice gap. The question that really needs to 
be addressed is this one: ‘Why is the policy-practice gap 
seen as pervasive and persistent in a system in which 
there are very many conscientious health professionals 
who subscribe to the broad principles of patient-centred 
healthcare and are increasingly educated in settings where 
these principles are strongly emphasised?’ A full answer to 
this question might quite reasonably include reference to 
professional conservatism or professional power, but other 
elements would need to be included. The argument of this 
section of the report is, in summary, that the gap between 
policy orthodoxy and routine practice is in major part 
produced by two overlapping factors: 
(i) patient involvement in clinical settings is ‘hard to do’ – it 
is very difficult to translate principle into practice; and 
(ii) patient involvement in clinical settings gives rise to 
substantial dilemmas – in many instances the resistance to 
forms of involvement does not spring from simple conservatism 
but from legitimate concerns about what is for the best.
In the rest of this section these two factors will be 
unpacked and discussed further. However, as has already 
been noted, the two factors cannot be neatly separated 
out. Part of what makes patient involvement difficult to 
implement is the fact that it involves the management of 
dilemmas. For this reason the two factors will be discussed 
in parallel. 
Understanding the policy-practice gap starts from the 
recognition that ‘involvement’ in practice is complicated 
– it can refer to a broad range of things and has to 
be interpreted in a broad range of contexts – and so 
there can be no standard answers to the challenges 
of involvement; this is true with regard both to the 
practicalities and the principles of involvement.
The components of involvement
As noted above, ‘patient involvement’ is really an umbrella 
category that covers a wide range of concerns and 
practices. Others have helpfully illustrated the open-ended 
nature of involvement, for example by indicating some of 
the questions that would need answering, case-by-case, 
before we would be clear about what kind of involvement 
we are talking about. For example: What kinds of activities 
should individuals be involved in? What kinds of relationships 
and people should individuals be involved with? Who are we 
imagining are the agents of involvement? i.e. who is supposed 
to initiate or support involvement for whom? (Entwistle & 
Watt, 2006).
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In this paper the central focus is on the potential 
contribution of patients to clinical exchanges involving 
medicines, including related clinical and health-related 
decision-making, and on the potential role that 
professionals have in facilitating this contribution. However, 
it is important not to define this focus too rigidly, not 
only because this agenda merges into other ones, as 
noted above, but also because the way any such agenda 
is constructed makes assumptions about ‘who is in charge’ 
or ‘who is responsible’ which is precisely the issue that is 
raised by involvement debates. 
To indicate some of the diverse things a professional who 
wishes to strengthen their ‘involvement practices’ may 
have to address, it is worth abstracting out eight different 
components of patient involvement practices. These 
components are designed to be indicative, and not in any 
way meant to be definitive or exhaustive (although they are 
based upon analysis of fieldwork on involvement and are 
thus certainly of relevance5):
1.  creating the conditions for communication; 
2.  informing and educating patients; 
3.  promoting self management; 
4.  being responsive to patient perspectives; 
5.  joint agenda-setting; 
6.  joint decision-making; 
7.  relationship building; and 
8.  re-working relationships and systems.
These components are discussed and illustrated in much 
greater depth in Appendix 1. They are introduced here 
because they help to indicate some of the complexity of 
involvement and provide a platform for further discussion. 
Not least, setting out this indicative list of components 
makes it evident that involvement is not just one thing 
(let alone one simple thing). For a professional to involve 
a patient can mean, for example, that they must engage 
with them, inform them, encourage and support them, 
listen to them, work collaboratively with them on defining 
problems and determining solutions, build rapport and 
trust with them and, at least some of the time, break out 
of the moulds which typically shape the ways in which 
professionals and patients interact. Even under the best 
of circumstances, none of these things are easy. To achieve 
a suitable combination of them in the ‘real world’ of 
healthcare is extremely demanding.
One major element of this challenge is that increasing levels 
of patient involvement requires the forging of new patterns 
and habits of relating in contexts where other patterns 
and habits of relating are institutionally and personally 
embedded. This can be seen by looking at what might 
seem like the ‘easy end’ of the involvement components 
listed above – the need to create and ‘open up’ channels 
of communication. Of course, all health professionals must 
have some level of communication skills and, of course, 
there are plenty of opportunities for communication 
between professionals and patients. However, the kinds 
of communication that are possible are structured, and 
limited, by the settings and circumstances of particular 
interactions. Even in primary healthcare settings – which 
are often seen as sites conducive to more open-ended and 
ongoing forms of communication – there are well-known 
time limits upon consultations, and patients (even if not 
professionals) often come to consultations with strong 
and long-reinforced notions of what is expected from 
each party. According to some of the leading conceptions 
of patient involvement - e.g. various models of ‘shared 
decision-making’ - patients ought to be helped to share their 
values and preferences about their experiences and possible 
treatment risks and outcomes and to collaboratively explore 
and deliberate about clinical and health-related decisions. 
This obviously requires specific forms and conditions 
of communication; i.e. if patients are to feel truly secure 
enough and to be sufficiently forthcoming and confident 
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to participate effectively. (And, as will be illustrated in more 
detail below and Appendix 1, the exact forms and styles 
of communication needed will vary depending on which 
of the various components of involvement - or which 
combinations – are stressed.)
There is no desire here to suggest that these broader 
forms of communication are impossible or that appropriate 
conditions do not exist. The intention is purely to stress 
that these forms of communication are definitely not 
easily achieved and to note that some conditions in 
which professionals and patients come together (e.g. in 
busy hospital clinics designed with specific functions in 
mind) are unlikely to support these richer kinds of patient  
involvement practices.
Moving from the general to the 
particular
Ideals such as ‘partnership working’, ‘shared decision-making’ 
or ‘concordance’ serve a range of important purposes. They 
encapsulate and help to explicate important principles, 
they signal and steer policy directions and models of 
professional practice, and they provide general frameworks 
and languages for research and development. However 
they are of only limited value when it comes to bringing 
about change on the ground. The reasons for this are mostly 
obvious. These terms are inherently abstract6. To know the 
terms, and even to embrace the broad ideas and principles 
they represent, does not resolve the question, ‘What 
should we do here and now, in this particular setting, in this 
particular instance?’ Still less does it resolve the question of 
how we make it possible (or easier) to do whatever it is we 
think should be done. 
Much important work has been done on this practice 
development agenda (see section 3), and this work suggests 
possible ways forward. As well as time, other resources need 
to be available – not least suitable ‘spaces’ for potentially 
more personally and emotionally invasive or more open-
ended interactions, new and/or extended forms of expertise 
for some professionals (and patients) and, in some instances, 
specific ‘tools’ (information sources, decision-aids, record 
keeping tools etc) to support involvement efforts. The point 
being underscored here is merely that practice development 
is something supplementary to, and rather different from, the 
articulation and dissemination of ideals.
A core problem with the dissemination of patient 
involvement ideals, therefore, is that it effectively involves 
translating ‘one big idea’ to a countless set of very diverse 
contexts. Patient involvement has to be translated into 
practices in different sectors and settings, for different 
professionals and patients, and for different kinds of health 
conditions and treatments. In the case of prescribing 
decisions, for example, there are very significant differences 
in what it is appropriate to call for in different cases. Just 
to indicate some relatively clear-cut differences: (a) the 
legitimate limits to professional influence or persuasion 
would seem to be different in relation to those medicines 
where there is the potential for addiction, abuse or public 
health risks7; (b) in some scenarios patient choice of 
medicines is much less practically or personally meaningful 
than in others (compare, for example, choice of rejection 
drugs as part of a transplant procedure and choice of 
HRT8 - in the former case there may be no real choice 
about whether to take medicines and no significant personal 
factors relevant to the choice of which medicines to choose; 
whereas in the latter case both kinds of choice are often 
both possible and personally meaningful); (c) professionals 
have their own prescribing philosophies and styles and it is 
unreasonable to expect them to accomplish things in exactly 
the same style providing they are broadly striving to achieve 
the same kinds of balances (especially in areas where the 
personhood of the professional is a key resource – see 
6 This abstraction incidentally means that such terms can easily be dismissed from the start as empty ‘policy jargon’ by practitioners. This is shown, 
for example, in studies conducted within the King’s Fund ‘Point of Care’ programme; an excellent source for thoughtful and penetrating ideas about 
what matters beyond the jargon (see Goodrich & Cornwell, 2008; and Goodrich, 2009). This work shows that professionals much prefer ordinary 
‘human’ words for caring such as respect, dignity, sensitivity, understanding or compassion.
7 For example, see the very careful and responsible discussion of ‘involuntary isolation’ as a last resort in TB care, following sustained efforts to 
explore effective and person-centred approaches to non-adherence in the WHO guidance on the ethics of tuberculosis prevention, care and 
control (WHO, 2010). Also see the debate about the ethical desirability and problems of ‘opioids contracts’ between doctors and patients in The 
American Journal of Bioethics, 2010(11).
8 See, for example, Légaré & Brouillette (2009); Murtagh & Hepworth (2003).
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section 3); (d) patients, of course, have different information 
and support needs in relation to medicines, and very 
varied perspectives and preferences including involvement 
preferences. (Some of this diversity, based upon practice 
examples, is illustrated in Appendix 1).
Thus what patient involvement can and should look like will 
vary from case to case, and the same applies to what counts 
as appropriate kinds of decision support or record-keeping 
tools and systems and, to some degree, the appropriate ‘skill 
set’ of professionals. As already noted, these things partly 
depend upon the immediate setting and the dominant 
‘function’ of the encounter between professional and patient. 
Some institutional settings and consultations lend themselves 
to richer forms of engagement and involvement than others. 
But equally important, different settings and functions suggest 
different involvement purposes and possibilities. To return 
to the components of involvement listed above, it seems 
sensible to suggest that these components might need to be 
prioritised (and interpreted) in different ways on different 
occasions. If the immediate job at hand is to support the 
patient’s self-management of their chronic condition through 
the most effective use of already prescribed medicines, 
then – crudely – components 1 to 4 are arguably the most 
salient. If the principal task is to initially identify a suitable 
medicines regime (or to review and rethink a regime), 
then components 4 to 6 are obviously central. Similarly, if 
professionals and patients are likely to have a more long-
term and open-ended relationship – for example either 
working on a treatment trajectory over a long period and/
or collaborating on service improvements, then components 
7 and 8 (along with others, depending upon the instance) 
become particularly prominent. 
This could be formalised by referring to different ‘models’ of 
involvement – some of which have been given names in the 
literature. Roughly speaking, as we move through the eight 
components, we are moving from what have been called 
‘informed adherence’ models to ‘self-management’ models 
to ‘shared decision-making’ models. These are all attempts 
to improve on an old-fashioned expert-based compliance 
model. The first part of this process is to help patients ‘get on 
board’ with clinical agendas – to involve them, for example, 
through education. This can merge into another part of the 
process, which is to recognise patients’ involvement in, indeed 
ownership of, their own health-related practices (which 
includes ‘adherence’ issues of course) and the need to 
focus on patients’ health-related perspectives and practices. 
This merges into the process of making decisions, including 
prescribing decisions, with patients as is represented in the 
idea of ‘the meeting of experts’ assumed by concordance or 
shared decision-making ideals. Through these various steps 
there is some re-negotiating of the boundaries between 
professional and patient roles and responsibilities. The 
emphasis in component 8 on ‘relationships and systems’, in 
the plural, serves as a reminder that the patient-professional 
dyad (which is the main focus here) always needs to be seen 
in a social and institutional context. 
Components 5 to 8 might be seen in some ways as 
potentially (and increasingly) more radical steps, because 
they suggest the scope for – at least to some degree – 
diminishing or even dissolving the boundaries that typically 
define the professional-patient relationship. However, it 
is worth cautioning against the simple idea that some 
components or models are inherently ‘lower’ or ‘higher’ in 
an involvement hierarchy, or of seeing more unconventional 
professional-patient relationships as necessarily more 
‘radical’ or as necessarily representing ‘more’ and therefore 
‘better’ involvement. To repeat the point just made, what 
counts as appropriate or ‘better’ involvement, and how the 
components (summarised above) should be interpreted 
and applied, depends very much upon the particularities of 
specific settings, purposes and cases. This means that there 
are two different axes to the complications of involvement: 
as well as a diversity of practice settings there is a diversity of 
possible conceptions and models of involvement
Understanding the ethical obstacles
Thus far the emphasis has been on what might be thought of 
as the instrumental or ‘organisational’ obstacles to closing the 
policy-practice gap; i.e. the need for various kinds of planning 
and resources, and problems in ‘operationalising’ involvement 
in ways that is appropriate to specific contexts. But nested 
within the above discussion are potential challenges of a 
different sort – relating to what might be thought of as 
ethical or principled concerns. 
The debate about suitable models of involvement can be 
interpreted in either a technical or an ethical way – as a 
debate about technical questions or about questions of 
principle. The above discussion puts the emphasis on the 
former; i.e. in order to optimise the benefits of patient 
involvement, bearing in mind the demands of different 
settings and cases, what is likely to be an effective and a 
‘fitting’ model of involvement in various instances? But, 
of course, the debate about models is about more than 
this. It is also partly about what we should think of as the 
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benefits and costs of involvement or what should count as 
effectiveness; i.e. it is also about purposes and principles. In 
other words, it is quite possible that two people could agree 
that an approach to involvement could be implemented in 
a particular context and even agree, to a large extent, about 
what the likely outcomes of implementing such an approach 
might be and yet disagree about whether or not such 
implementation would be a good or a bad thing.
Professionals can have a variety of principled worries about 
practical approaches to involvement and it is a mistake to 
see all reservations about patient involvement as a simple 
expression of professional conservatism or paternalism. If 
this fact is not understood and addressed, there is no hope 
of optimising levels of patient involvement, because policy 
makers may appear to professionals to be ‘pushing’ them in 
directions which they see as unprofessional and wrong. The 
result of this can only be a stalemate between two well-
intentioned sets of agents. 
This is not to say that the general practical and ethical 
importance of patient involvement is in any doubt. As 
summarised above, patient involvement is ethically important 
because it treats individuals (and groups) with respect and 
because it can have beneficial consequences in relation to 
quality of care and health outcomes. The legitimate concerns 
about whether, where and to what extent involvement is 
‘a good thing’ only arise when we focus in more closely. 
To summarise these concerns: first, there is the question 
of whether and how far the ideals which underpin broad 
conceptions of involvement are actually made manifest when 
involvement is translated into practice; and second, there is 
the question of how to balance together different ethically 
relevant considerations when they come into conflict. 
A responsible professional needs to be able to confront the 
following value-based questions: 
  What if there is some doubt about the capacity of 
patients to represent themselves effectively?
  What if patients do not want to be involved in  
particular ways?
  What if attempts to involve patients cause them anxiety 
or distress?
  What if actions or interventions to promote 
involvement undermine the trust patients have in 
clinicians, or the comfort and reassurance that clinicians 
can offer? 
  What if ‘involved’ patients make choices that are harmful 
to themselves, or to others, or damage the public realm 
more generally (for example, because they are very 
expensive, or otherwise adversely affect public health)?9
There is not space, and it is not appropriate, to offer 
an in-depth response to these questions here, but it is 
worth unpacking them each a little further to show their 
importance and some of the challenges of responding to 
them. It is also worth repeating in advance that none of 
the questions are meant to undermine the general case for 
involvement; rather they simply indicate concerns which 
taken together show the ethical importance of ‘tailoring’ 
involvement carefully.
Problems of capacity - It is well known, in relation to informed 
consent processes, that patients’ autonomous (unpressurised) 
choice to consent to, or refuse, treatment must be respected, 
assuming that patients meet necessary thresholds of 
competence and understanding. It is also well known that 
in some real world cases clinicians have to make careful 
professional judgements about whether these thresholds 
are met and, in either case, how to tailor information and 
conversations to best meet the varying needs of different 
patients. In practice, these judgements cannot be based 
on some exact formula but are necessarily based upon 
professional experience, sometimes including ‘educated 
guesstimates’. There is also not one fixed level of capacity for 
each individual patient because the capacity for independent 
autonomous judgement can vary depending upon the social 
and emotional conditions individuals find themselves in and 
the kinds of circumstances and choices they are faced with. 
In essence, professionals are faced with deciding when a 
degree of paternalism may be called for; i.e. when it might 
be justifiable to promote the interests of patients in ways 
that effectively ignore rather than follow patients’ expressed 
preferences. In the case of informed consent, it is clear that 
setting aside patient preferences has to be the exception 
rather than the rule and that, even then, steps must be taken 
to limit exercises of paternalism (for example, by involving 
family members to help represent the interests of patients). 
The crux of informed consent is that it should protect 
9 See Cribb, Donetto & Entwistle (2011) for a similar list of questions – the discussion here was written in parallel with the discussion there.
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patients from unwarranted paternalism and that patients 
should not be subjected to clinical interventions which they 
say they don’t want, unless exceptional conditions apply.
However, the situation is less clear-cut with much richer, and 
more demanding, models of involvement. If more full-blown 
shared decision-making models are applied to prescribing 
decisions, for example, there is the potential for high levels of 
exchange of information and perspectives between patients 
and professionals, including the sharing of clinical expertise 
on the evidence base relating to specific medicines. Patients 
will have very varied capacities (and desires – discussed 
next) to engage in these exchanges including, for example, 
in detailed technical discussions. Here clinicians have to 
make analogous professional judgements about when it 
is unrealistic and unproductive to pursue certain lines of 
communication. This is especially important because there 
is a real risk that some approaches to communication 
may not only be unproductive but may also be ethically 
counter-productive – because in practice they may generate 
confusion and thereby undermine the clear lines of 
communication that are necessary to ensure that the basic 
conditions of informed consent are met. 
Unwanted involvement - One factor in determining the right 
kind and level of involvement is the question of how much 
involvement is wanted by individual patients. Respect for the 
patient’s autonomy means that, not only patients’ expressed 
preferences about treatments should be respected, but 
also that similar consideration should be given to their 
preferences about involvement. As with treatment decisions, 
there may be some room for joint discussion and negotiation 
about the right levels of involvement (it cannot just be 
assumed that whatever preferences about involvement are 
encountered or expressed in the first instance necessarily 
represent the patient’s considered, stable and autonomous 
decision about involvement), but patients’ considered 
preferences need to be taken seriously. This creates potential 
dilemmas for professionals who may have very good reasons 
to wish to encourage greater levels of patient involvement 
(in prescribing decisions, for example), but at the same time 
need to avoid oppressive forms of ‘enforced involvement’. 
Of course involvement is not an ‘all or nothing’ thing and, 
even if a patient clearly signals they are not interested in 
actively participating in prescribing decisions, it is still possible 
to aim for forms of professional recommendation and 
leading of decision-making that optimise respect for patients 
and support their autonomy (Entwistle, Carter, Cribb, & 
McCaffery, 2010).
Creating distress - If involvement strategies cause distress in 
certain cases, then that might be a reason for dropping or 
moderating them in those cases. However, there should not 
be a presumption that anxiety or distress are necessarily and 
always bad things, and they can even be seen as appropriate 
responses in some situations – side-effects that are, on 
occasions, unavoidable in the sometimes painful processes 
of facing and making decisions. This is certainly a common 
feature of non-clinical life choices. Attempting to elicit 
patients’ values and preferences is often a critically important 
element of determining what is ‘clinically appropriate’. Unless 
prescribers have some sense of individual patients’ values 
and preferences then they are often not in a position to 
make the right judgements, because what counts as ‘right’ can 
depend upon knowing what patients hope and expect to get 
from treatment (and what they want to avoid, for example, 
in terms of side-effects). In particular, in all those cases where 
the relative costs and benefits of different treatments are 
broadly comparable or uncertain it makes sense to attach 
considerable weight to eliciting and reflecting the preferences 
of patients in determining the ‘right’ treatment (including no 
treatment). This is the central rationale for shared decision-
making approaches. So, whilst it is clear that the creation 
of anxiety or distress is an ethically relevant factor here, as 
above, there are genuine dilemmas about how far a degree 
of anxiety might be outweighed by the advantages of greater 
patient involvement, providing, of course, that the level 
of anxiety is not so high as to preclude the possibility of 
effective involvement.
Undermining trust and support - Another legitimate concern 
about the unqualified promotion of greater levels of patient 
involvement in clinical decision-making is that this has the 
potential to undermine the trust that patients have in 
professionals and the opportunities for professionals to 
offer support and reassurance to patients. As has already 
been suggested in relation to each of the three concerns 
already discussed, it would be counter-productive to insist 
on forms of involvement in those instances where doing so 
would undermine the foundations of effective professional-
patient relationships. However the possible damage 
to professional-patient relationships depends on how 
involvement is accomplished. It is easy to imagine clumsy 
‘involvement interventions’ that would undermine patient-
professional relationships and trust, but there is no reason 
to suppose that all approaches to involvement would have 
these consequences. Indeed, there is reason to suppose that, 
done well, the facilitation of patient involvement would tend 
to enhance the quality of patient-professional relationships. 
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From patients’ perspectives, the right ‘style’ can be particularly 
significant for a sense of involvement (Burkitt-Wright, 
Holcombe, & Salmon, 2004; Entwistle, Prior, Skea, & Francis, 
2008; Fraenkel & McGraw, 2007; Levinson, Kao, Kuby, & 
Thisted, 2005).
Bad outcomes - Finally, there is the question of whether the 
promotion of involvement, particularly if this involves offering 
patients more options and/or more influence over which 
medicines are prescribed for them, could, in practice, result in 
‘bad outcomes’. The phrase ‘bad outcomes’ is being used here 
as shorthand for a broad range of phenomena – the ‘badness’ 
of some of which would be contested - including costs and 
risks to the health of the individuals concerned, the public 
purse or the public health (for example, if patient choice led 
to more widespread and costly use of antibiotics and also 
compromised herd immunity). The risks, in some instances at 
least, to the professional-patient relationship (just discussed) 
provide another potential example, as does the possibility 
that certain approaches to involvement may actually reinforce 
health inequalities (for example, by further advantaging 
those who are the most assertive ‘consumers’ of healthcare). 
Once again, there is only space here to indicate this family of 
concerns and risks, rather than to further unpack or analyse 
the many complexities and controversies they generate. But 
these concerns certainly help to provide an argument against 
unfettered patient choice of medicines. 
However choice and involvement are not the same things, 
and arguments for patient involvement in the form of 
shared decision-making or concordance are not arguments 
for excluding clinicians from decision-making. Concordant 
approaches to prescribing mean that professionals maintain 
essentially the same kind of control over access to potentially 
harmful medicines. Indeed, as the language of ‘shared 
decision-making’ makes explicit, clinicians would still retain 
their own responsibility for decision-making and would 
remain professionally accountable for decisions made about 
prescription only drugs. This final point merits underlining. 
Responsible professionals have to be ready to attend to the 
value-based questions reviewed here, and to navigate the 
ethical dilemmas raised by involvement practices, because 
they are professionally accountable for their participation 
in decision-making. In fact, another way of indicating the 
practical and ethical obstacles facing the implementation 
of shared decision-making, and of summarising the overall 
ethical challenge, is to ask, ‘how can we both extend patient 
involvement and protect professional accountability?’
In summary, all of the ethical concerns reviewed here 
can be related to good arguments for limiting patient 
involvement – at least in certain forms – but none are good 
arguments for the wholesale rejection of increased patient 
involvement. Rather, they are arguments for placing limits on 
the medicines that people can choose to have and, more 
generally, for tailoring approaches to involvement in ways 
that reflect these legitimate concerns.10
The issues rehearsed here show how misleading a simple 
deficit picture of professionals can be. The notion that 
the ‘drag’ on the promotion of more patient involvement 
is simply the conservative attitudes of professionals (or 
patients) obscures many crucial matters. Increasing levels of 
patient involvement entail considerable practical challenges 
and amongst these are the ethical challenges of tailoring 
involvement practices in ways that balance competing 
considerations together. The operationalisation of patient 
involvement is shot through with professional dilemmas. Of 
course one of the central values in healthcare ethics is that 
professionals should respect the autonomy of patients, but 
(a) it is not always straightforward to know what that entails 
in specific cases, and (b) following the choices of patients 
(even when we feel reasonably confident that these are 
autonomous choices) can, on occasions, conflict with other 
important values such as patient protection or the public 
interest. Professionals are accountable for the practices they 
engage in, including the forms of involvement they facilitate, 
and they cannot choose these practices lightly.
If we are interested in closing the policy-practice gap in this 
area, then we need a good understanding of the factors 
that produce it. Repeating abstract policy ideals and slogans 
will not be enough. This is especially so if, as sometimes 
happens, ideas with very different meanings, and with a 
range of possible interpretations, are ‘fudged together’ as 
if they all essentially mean the same thing and require the 
same strategies (for example, if ‘shared decision-making’ 
and ‘patient choice’ are equated). Even where more clearly 
defined and differentiated goals are specified, the problems 
of implementation are not primarily problems of will power 
but problems of putting practical resources in place. Amongst 
these resources are professional skills. But the skills which 
are needed are not narrow technical competences – for 
10 Although it is worth noting that the arguments presented here for ‘tailoring’ involvement could equally plausibly be presented, using a more   
contentious language, as arguments for ‘restricting’ involvement, depending upon cases and purposes. 
INVOLVEMENT, SHARED DECISION-MAKING AND MEDICINES 18
11 This was a theme that also arose in the fieldwork which fed into Appendix 1 (and other elements of this discussion paper) and was 
repeated by several key informants.
12 Although this discussion paper is not the place for an ideological analysis of involvement policies it may be worth noting in passing that the 
different ‘versions’ of involvement, person-centredness or shared decision-making (alluded to in this and the next section) have partial affinities 
with different ideologies of healthcare organisation, and thus ethical debates about involvement cannot be neatly disentangled from political 
debates. At the same time it should be stressed that (a) connections between ‘involvement models’ and political ideologies are not at all 
straightforward , and (b) both ‘consumer/choice’ and ‘collective/democratic’ policy tendencies co-exist in mainstream UK health policy, with the 
rhetorical balance between them varying in constituent countries.
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example, an understanding of the principles of involvement 
plus generic communication skills – they are some of the 
most demanding kinds of practical wisdom that make up 
professionalism in its fullest sense (discussed further in the 
next section). 
The risks of counter-productive 
policy
Before finishing this section it may be worth stressing that 
focusing on these ethical challenges is not merely of abstract 
or philosophical importance. Unless we are clear about the 
various ‘goods’ and ‘bads’ at stake, there is always a risk that 
well-intentioned policies or practices may have negative 
side effects, and may even, as far as respect for patients is 
concerned, be counter-productive. 
Whilst striving to enhance the levels of involvement afforded 
to patients we need to keep a clear-sighted view both of the 
‘real world’ circumstances we are working in and of the range 
of ‘goods’ that matter. Recent reports from the Ombudsman 
(Parliamentary and Health Service Ombudsman, 2011) 
and Care Quality Commission (2011) as well as recent 
publications by The Patients Association (2010) shows how 
there are instances within the NHS where the basic levels 
of respect and dignity that should be afforded to individuals 
are simply not delivered. Correcting this is unquestionably 
an ethical imperative. Obviously this depends upon the 
standards of individual healthcare workers and their 
personal and professional values. However, these need to 
be underpinned by attention to the structures and cultures 
within which people work. No one could deny that basic 
respect and dignity is of central importance but, even here 
or especially here, we cannot simply rely on the assertion of 
these values; rather we need to take steps to embed them 
in practical settings. Exactly the same is the case for the more 
subtle, and more interactive, forms of respect reflected in 
models of involvement. 
The apparently extreme example of undignified treatment 
is relevant for another reason. Whilst we cannot afford to 
postpone strategies for greater patient involvement until 
we have guaranteed basic dignity for all, we need to be 
careful that within specific services and settings we are not 
attempting to run before we can walk.11 
For example, Mol (2008: 84) argues:
When in interviews - or elsewhere - patients complain about 
bad health care, they may mention that they were not given  
a choice, but more often they talk about neglect. They describe 
how their particular stories or personal experiences were not 
attended to. They would have appreciated more action and 
more support … The point is not that people boss you about, 
but that nobody cares.
Mol uses this kind of observation as part of a broader critique 
of what she calls the ‘logic of choice’ as opposed to the ‘logic 
of care’. Whether or not someone wishes to endorse her 
general critique of choice policies12, everyone ought to be 
sensitive to the insights that: (i) ‘choices’ offered to patients are 
unlikely to be meaningful ones unless the basic foundations of 
respect and care are in place; and (ii) there may be occasions 
– as the above summary of ethical dilemmas indicates – 
where there are significant tensions between engaging people 
in choices, on the one hand, and respecting their wishes and 
caring for them, on the other.
As the five ‘ethical obstacles’ just reviewed all demonstrate, 
professionals frequently have to balance together the 
‘minimum’ they owe to patients in relation to involvement 
and the ‘maximum’ kinds and levels of involvement that 
are possible in principle but do not always seem relevant 
or practicable. In all cases professionals should be treating 
patients with respect and, in relation to treatment choice, 
ensuring informed consent. Other, richer and more open-
ended, forms of involvement may also be possible and 
desirable but nothing done in their name should threaten the 
foundation of basic respectful relationships.
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3. CLOSING THE POLICY-PRACTICE GAP
Two broad lessons emerge from the analysis of the policy-
practice gap in the previous section. First, the analysis 
suggests that more work needs to be done at both ends 
of the policy-practice divide. Policy ideals need to be 
further specified and supplemented by richer conceptions 
of the nature of health professionalism and by a range 
of more differentiated models of patient involvement 
that reflect the diversity of practice. At the same time, 
it is necessary to identify a number of feasible ‘stepping 
stones’ to help translate these ideals into diverse practical 
contexts; steps that can be developed and implemented in 
existing healthcare settings without waiting for wholesale 
transformations. It is also important to explore more 
transformative notions, of course, providing the challenges 
of making such transformations are acknowledged. In short, 
policy development and practice development need to be 
better connected. Second, and this is arguably the central 
lesson, there is a severe limit to how far the changes sought 
can be achieved by using standardised recommendations or 
purely ‘technical’ strategies. Both the ethical and the other 
practical challenges of implementing higher levels of patient 
involvement call for context-specific, flexible and imaginative 
professional judgment or what philosophers, following 
Aristotle, often call ‘practical wisdom’13. There is certainly an 
important role for guidelines and other tools and practical 
resources but the value of these things depends upon and 
cannot replace healthcare professionalism. The remainder of 
this section will expand on these lessons, reflecting upon the 
challenges of renewing professionalism, developing practice 
and, in particular, of closing the gap between guidelines and 
practice in the area of medicines prescribing and adherence.
Renewing and strengthening 
professionalism
The policy orthodoxy surrounding patient involvement 
contains more or less explicit models of what is 
often labelled as ‘new professionalism’. Whereas ‘old 
professionalism’ is represented as paternalistic (and generally 
‘top-down’), new professionalism is based on partnership 
and is ‘patient-centred’ or ‘person-centred’. In some respects, 
the shift to new professionalism is portrayed as something 
that is well underway as a product of broader historical and 
cultural change, as new generations of ‘providers’ and ‘users’ 
take their places in evolving public and health services. In 
other respects, this shift is seen as something which needs 
to be further developed, steered and underpinned by policy 
initiatives, models and guidelines on good practice, and new 
educational approaches, all designed to remedy the deficit of 
the old professionalism.
In this context of helping to create, guide and support 
new forms of professionalism, policy ideals and models 
such as ‘patient involvement’, ‘shared decision-making’ or 
‘patient-centred’ care make sense and are valuable. They 
help to articulate and disseminate visions of reformed 
practice.  Their limitation is that they are typically expressed 
in generalised ways. As a result, they are more helpful in 
identifying what might count as bad practice than they 
are at specifying good practice. Take the notion of ‘patient-
centredness’, for example.
Patient-centredness is an extremely elastic notion that 
seems to be able to accommodate all but the most 
unresponsive, uncaring or solipsistic forms of professional 
behaviour. It accommodates a range of things which, whilst 
13 It is impossible to give a full account of practical wisdom here but, in summary, it is that form of practical knowledge which is concerned with 
the quality of activity itself and not only the quality of the products of activity. We are used to the idea of distinguishing between ‘good work’, in the 
instrumental sense of work that produces good products or results, and ‘good work’ in the broader sense of ethical or ‘virtuous’ work. Obviously both 
‘good results’ and ‘good actions’ are important if we are to judge a health professional to be good overall but we can make sense of the distinction 
being made here. The former requires technical knowledge and the latter requires something more - practical wisdom. In the case of practical 
wisdom the means-end rationality associated with technical knowledge directed at achieving certain results is insufficient. Rather than being 
determined by the specification of any instrumental object or end, what matters and what is being pursued in practical wisdom includes the right 
kind of conduct. In trying to act with practical wisdom we must be ready to deliberate about both the means by which the ends of an activity are 
achieved and the ends themselves, and this requires the capacity to make discriminations not only about instrumental claims but also about what 
is most valuable case by case - and on that basis, to make judgements about the best (most virtuous) forms of conduct and ways to act in each 
set of circumstances (see, for example, Hursthouse, 1999).
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important in their own right, can be in tension with one 
another, for example: (a) a concern with respecting and 
protecting patient dignity;14 (b) a concern with responding 
to the particularities of the individual patient (i.e. properly 
utilising biological, psychological and/or social facts about 
the individual);15 (c) a concern with fully taking note of and 
taking into account patients’ subjectivities or life-worlds 
and in particular patients’ preferences of various kinds; (d) 
a concern with some degree of shared decision-making 
(or shared control/power/responsibility etc.) between 
professionals and patients; (e) a concern with fostering 
quasi-consumerism where the goal is to offer a range of 
service choices and to develop services and systems that 
are more responsive to patients’ demands. These items are 
not necessarily incompatible with one another. But these 
dimensions of patient-centredness can be incompatible 
with one another and, exactly as was illustrated through 
the discussion of dilemmas in the previous section, ‘good 
practice’ is crucially dependent on an understanding of the 
tensions between these things and of how tensions might  
be managed from circumstance to circumstance, and   
case to case.
It is clear that a professional who had little regard for a 
patient’s dignity, was inattentive to the distinctive biological or 
social needs of this particular patient, took no interest in the 
patient’s concerns and preferences and excluded the patient 
from key decisions would be a very bad professional! But it 
is far from clear what an ‘ideal professional’ would do if he 
or she, as they undoubtedly would, cared about all of these 
things. This is because there is very extensive scope for both 
contestability and variability with regard to these matters. 
That is to say, there is: (i) room for disagreement about how 
each of these considerations should be interpreted and 
how these (and other) considerations should be balanced 
where they pull in different directions; and, in addition, (ii) 
a need for a range of different emphases both to reflect 
diverse clinical contexts and to reflect the different ‘personal 
styles’ and orientations of professionals and patients. This 
complexity echoes the complications rehearsed in the 
previous section about the problems of translating policy 
ideals into practices suited to specific settings and cases – a 
translation that involves addressing intertwined practical (i.e. 
organisational and ethical) challenges.
Given this complexity, tightly defined and prescriptive 
methods of professional regulation (for example, 
performance management approaches or ‘tick box’ 
protocols) are of limited value because, beyond a point, they 
are positively corrosive of the qualities needed to deliver 
patient involvement in two respects: (i) for the reasons given 
above, case-by-case professional judgement is an ineliminable 
element of skilful and successful patient involvement 
practices; guidelines have a place here but only so long as 
they do not become too narrowly defined or implemented; 
and (ii) in some instances patient involvement involves a 
‘human’ (and voluntary) engagement between professional 
and patient that can be quite demanding of the personhood 
and emotional resources of professionals. In these instances 
‘authentic motivation’ is a necessary ingredient of good 
practice and of what is valued by patients. There is a deep 
tension between this kind of ‘genuineness’ and the kind 
of motivation generated by compliance with governance 
regimes. This is not to say that there is no place for the 
use of incentives to drive change but rather that incentives 
cannot solve every problem, should always be accompanied 
by a health warning about side effects, and should – where 
possible – be used as (at most) one element of a broader 
professional development process rather than instead of one.
14 The King’s Fund Point of Care programme reports an emblematic example of the ‘failure to see the person in the patient’: Significantly, the 
ambulance crew were the only people in the entire seven weeks who formally introduced themselves and asked what she would like to be called. 
Thereafter, for the first six weeks of her admission, she was called Elizabeth, which is her first name, which she has never been called in her life, 
ever. She’s only ever been called by her middle name. But the NHS IT system records your name. All her labels were wrong. In spite of the fact that 
on a daily basis all of us told the people caring for her that her name is Margaret, and that is what she likes to be called if they want to call her 
by her first name, all of them called her Elizabeth. And that became very significant when she became confused. (Goodrich, & Cornwell, 2008: 9). 
15 Many of the uses of ‘personalised medicine’ fall into this category – what these uses refer to is an extension of biomedical science to properly 
reflect individual variation rather than a concern with patient agency and preferences. See, for example, Personalised medicine: hopes and realities. 
(2005). The Royal Society, London.
21 INVOLVEMENT, SHARED DECISION-MAKING AND MEDICINES
C
LO
SI
N
G
 T
H
E 
PO
LI
C
Y
-P
R
A
C
T
IC
E 
G
A
P
The key point to underline here is that just as specific 
approaches to involvement run the risk - in the ‘wrong 
circumstances’ – of being counter-productive, so too do 
some of the mechanisms that have been designed to ‘steer’ 
professionals away from ‘old-fashioned’, disrespectful or 
ineffective models of working. This is because they easily 
slide into mechanisms that undermine professionalism itself. 
This fundamental danger is increasingly recognised and 
articulated not only by professionals on the ground but by 
thoughtful analysts and commentators (e.g. Green, 2010; 
Iles, 2011). In UK healthcare this danger is particularly acute 
because powerful converging currents in clinical governance 
(linked with evidence-based healthcare) and in public 
service reform (linked with managerialism) both have strong 
‘technicist’ dimensions and thus, particularly in combination, 
have the potential to be counter-productive in this way. 
Through attempting to specify what counts as ‘appropriate 
care’, ‘good practice’ or ‘quality’ and through attempts to 
guarantee the ‘delivery’ of these specified services, these 
currents (unless they are very carefully circumscribed) risk 
seriously undercutting the agency, humanity and discretion of 
professionals – the core qualities that make appropriate and 
good quality healthcare possible. These potentially counter-
productive currents are also manifest in, and reinforced 
through, narrow and impaired discourses of, and conceptions 
of, practical knowledge and education, that tend to equate 
professionalism with the exercise of ‘competences’ or ‘skills’. 16
In a climate where healthcare is strongly managed and one 
in which the language of involvement exerts a powerful 
rhetorical force, there is a danger – discussed extensively in 
academic fields like sociology – that policies and practices 
are ‘sold’ as forms of patient involvement but are really no 
more than alternative forms of steering patients (as well as 
professionals). That is, there is a risk that patient involvement 
comes to be used as a more subtle and benign-seeming 
means of ‘managing’ patients. These are murky waters and 
there are no easy ways of capturing the distinction between 
‘inviting patients to help make decisions’ and ‘steering’ 
them;17 but everyone can recognise this possible hazard 
from examples of supposed ‘shared decision-making’ in their 
own personal lives. However, it is characteristic of rich and 
reflective forms of professionalism that professionals are at 
least aware of these dangers and are sceptical about ‘public 
relations’ uses of involvement to describe practices which are 
not essentially different from so-called ‘old professionalism’. 
More widely, a number of people have voiced concerns about 
the risks of policy drivers, whilst being aimed in some sense at 
the overall good, creating or exacerbating tensions between 
the interests and perspectives of individual professionals and 
patients. This has been discussed, for example, in relation to 
the prescribing of statins, specifically in relation to the difficulty 
of achieving a balance between population-oriented and 
patient-oriented practices (Sculpher, Watt, & Gafni, 1999; 
Peckham & Wallace, 2010; Hann & Peckham, 2010).
This worry about the corrosive (and counter-productive)18 
effects of ‘pushing’ involvement agendas though managerialist 
means is not a trivial one. As Green (2010), Iles (2011), 
and others, have argued there is the growing potential 
for a profound malaise in healthcare and public service 
professionalism. The only way to respond to the threat of 
this malaise is to ensure that strong and ’deep’ approaches 
to professional leadership and professional education assert 
and reassert the crucial role of ‘practical wisdom’ as intrinsic 
to professionalism. This means a renewed investment in both 
collegial and democratic currents of professionalism as checks 
and balances against managerial currents.19   
16 It is arguable that these limited conceptions of the nature of practical knowledge play an especially corrosive role in this area. The risk is that 
education for patient involvement is reduced to training in communication ‘behaviours’, when practical wisdom (based on a broader understanding 
of involvement ideals and challenges) should be centre stage. For very good analyses of the philosophical shortcomings of narrow conceptions of 
practical knowledge, written from contrasting philosophical perspectives, see Lum (2009) and Winch (2010).
17 Some of the respondents in the empirical study that informed Appendix 1 volunteered this concern and ‘admitted’ to the sometimes thin line 
between ‘involving’ and ‘managing’ patients. This possibility has been reported elsewhere (e.g. Jones et al., 2004; DoH & Farrell, 2004).
18 Counter-productive in the sense discussed at the end of the previous section, i.e. policies that are supposed to produce more respectful 
relationships with patients having the practical effect of undermining respect.
19 Strikingly similar points have been made in recent major contributions to the study of ‘performance regimes’ in the UK public sector (e.g. 
Walshe, Harvey, & Jas, 2010; Talbot, 2010). For example, Colin Talbot (in Walshe, Harvey, & Jas, 2010, p283) notes how despite the official 
commitment of contemporary UK governments to a ‘balanced approach’ to better public services which recognises the importance of building 
capacity and capability (including professional leadership and development) and of users shaping services, ‘in practice for most of the past twenty 
years central governments of both main parties have adopted very clear priorities in performance interventions: first, top-down managerial 
interventions; second, systemic-competitive interventions (league tables, internal markets, etc.); and only a poor joint third a focus on capacity and 
genuinely empowering users (as opposed to rhetoric about the idea)’.
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Overall we need to move beyond the simple ‘old’ versus ‘new’ 
models of professionalism debate towards richer conceptions 
of professionalism which are not about picking the one right 
model or approach but about having the experience and 
wisdom to pick models and approaches according to the 
circumstances and cases at issue (Cribb, Donetto, &  
Gewirtz, 2009).
Developing practice
This paper is largely focused on the broad policy challenge 
of patient involvement in relation to medicines choices 
rather than on the ‘nuts and bolts’ of bringing about change 
on the ground. Nonetheless, these ‘nuts and bolts’ matters 
are crucially important if policy rhetoric is to be something 
more than rhetoric. For the reasons set out above, the 
most important platform for practice development in 
this area is the collegial and educational cultivation, and 
institutional facilitation, of rich forms of professionalism 
embodying practical wisdom. However, providing this 
platform is put in place, attention also needs to be paid to 
putting in place concrete ‘stepping stones’ towards more 
meaningful and effective patient involvement practices. 
Exactly what suitable stepping stones will look like – 
given the importance of context sensitivity and practical 
wisdom – will depend very much on the circumstances 
and what are judged to be both helpful and practicable 
steps (and in turn, of course, this depends upon the specific 
purposes of different involvement practices). But those 
who are committed to practice development do not have 
to start from a blank sheet of paper: there are important 
and carefully trialled examples of successful initiatives to 
draw and build upon. In the remainder of this section 
the importance of two broad styles of work in this area 
of practice development will be briefly summarised and 
contrasted. The hope is not only to provide some quick 
indication of useful directions but also to indicate some 
of the underlying contrasts between approaches and the 
broader policy choices that need to be made.
All relevant work on practice development will, of course, 
emphasise similar themes, most notably the importance of 
effective professional-patient communication and hence 
communication skills, and the potential for developing 
and using information and communication aids or tools 
(whether paper- or web-based) to support communication 
and decision-making. However, they will vary in the 
emphases they place upon the broader purposes of, or 
‘visions of ’, patient involvement practices. As with the ‘old’ 
versus ‘new’ professionalism debate, discussed above, the 
task of the reflective professional is not necessarily to 
identify the single right answer here but to understand  
the possibilities and their relevance for their own contexts 
of practice.
Probably the most developed body of practice here is 
that originally associated with the Foundation for Informed 
Medical Decision-Making (FIMDM) (see http://www.
informedmedicaldecisions.org/). FIMDM has made a major 
contribution to the understanding of, and research and 
policy on, shared decision–making. This contribution is not 
purely theoretical but includes demonstration sites and 
the ‘rolling out’ of practice. The driving rationale of the 
approaches they have developed is the improvement of 
the quality of medical decision-making by attempting to 
ensure that relevant patient perspectives are incorporated 
in the process of decision-making; hence the label 
‘informed medical decision-making’. This approach includes 
the development of ‘patient decision aids’ – tools which 
provide patients with the evidence-based information they 
need to understand the clinical choices they are facing 
and which can also help them clarify and articulate their 
own values and preferences regarding possible treatments 
(including no treatment).20 These decision aids can also 
be used in conjunction with various forms of intervention 
from others to help enable, encourage or support patient 
involvement in decisions. In short, this might be thought of 
as a ‘decision improvement’ approach to involvement – it 
improves clinical decision-making both by ‘informing’ the 
patient about the things they need to consider and by 
‘informing’ the clinician about what matters to the patient. 
This approach to practice development also has included 
20 For related research see, for example, Légaré et al. (2003), O’Connor et al. (2003) and Elwyn et al. (2006). A fuller explanation of patient 
decision aids, and an A to Z searchable inventory of decision aids, can be found on the Ottawa Health Research Institute website (see http://
decisionaid.ohri.ca/).
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attention to quality standards for decision aids and the 
potential use of policy incentives (including financial 
incentives) and legislation to underpin the delivery of 
the improved decision quality.21 Although this tradition 
of work owes much to North American colleagues, 
researchers in the UK have also had a longstanding interest 
in this area and made substantial, critically reflexive and 
internationally influential contributions to its development 
and dissemination (for example, see Coulter, 1997, Elwyn 
et al., 2003 and Edwards et al., 2006). Similarly, there are an 
increasing number of directly related practice development 
initiatives in the UK.22 
There is a strong research base showing the potential 
for this kind of approach although – for the reasons 
summarised above – we should of course be wary of 
seeing any approach as in itself a ‘magic bullet’. There is 
plenty of evidence of important benefits from the use of 
decision aids, for example, but there are some questions 
remaining about whether the evidence accumulated so far 
is as strong on some indicators as it is on others.23 There 
are also some significant theoretical critiques of decision 
aids – for example, questioning the extent to which they 
can construct the nature of decisions in either realistic or 
neutral ways (Nelson, Han, Fagerlin, Stefanek & Ubel, 2007; 
Stiggelbout et al., 2004; Stiggelbout et al., 2008). However 
assuming that they are implemented in a flexible and self 
critical way and with thought given both to how they might 
be suitably adapted to, or developed for, specific functions 
and contexts and to the appropriate kind of support 
(where necessary) needed to enable their effective use, 
then such criticisms lose much of their force.24 
Of course there is no intention here - as part of such a 
broad-brush summary – to offer an overall evaluation of 
this or any approach. All that it is important for current 
purposes is to underline the point that this approach is 
designed to serve a fundamentally important function. It is 
a response to the fact that, at least on many occasions, both 
knowing what counts as a good quality clinical decision 
(even on quite a narrow conception of clinical goals) and 
being able to make such a decision depends upon knowing 
what matters to the patient. When different clusters of 
potential benefits, challenges, side-effects and risks have to 
be weighed together the way in which the clinician involved 
– if they were the patient - would weigh these together  
is not the main issue. By contrast the preferences of   
the actual patient with regard to these things is of  
central importance.25 
This approach to shared decision-making – leaving aside 
whether and how decision aids or other specific tools 
and techniques are used in it – therefore attends to the 
question of how key clinical decisions can be properly 
responsive to patients’ concerns and preferences. But, 
as was discussed in section 1, involving patients in 
clinical decisions in this way (although of fundamental 
importance) can be seen as relating mainly to ‘one 
direction’ of involvement. There is also the overlapping 
question of how clinicians and clinical work might more 
21 A very good recent overview of this approach and these issues is offered in Moulton & King (2010).
22 For example, quite recently the first few patient decision aids have been trialled on the NHS Direct website, and Health Dialog and other 
agencies are working in the UK to disseminate the model of decision improvement tools and practices. 
23 The review of systematic reviews by Coulter & Ellins (2007) of ‘strategies for informing, educating and involving patients’ (in their care generally 
– not just in relation to prescribing and medicines use) shows a mixed evidence base. Good evidence exists for the benefits of patient decision 
aids and for the provision of coaching and question prompts to enhance the capabilities and confidence of patients in relation to participation. 
However, most of the demonstrated benefits of these interventions relate to comparatively ‘soft’ (although nonetheless important) outcomes. For 
example, communication and coaching interventions can improve participation in decision-making, and patient decision aids have been shown to 
improve patients’ knowledge and understanding and ‘to improve agreement between patients’ preferences and subsequent treatment decisions’ 
(p26). There is much less clear evidence of similar impacts from these efforts (to improve clinical decision-making through patient involvement) on 
subsequent health behaviours and health status (p25).
24 But it should be noted that, the more these conditions apply, the more resource intensive these tools become, with regular work having to be 
invested into adapting them according to circumstances.
25 Of course, there are cases where understanding the preferences of the patient may play a reduced role in determining the quality of clinical 
decisions – for example, where there is no significant choice, or where the cost-benefit differences between available options are dramatically large 
and there is thus no real diversity in different patients’ preferences. But this still leaves other reasons for engaging with patient preferences which 
might feature in broader conceptions of ‘quality’.
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broadly support patients’ health-related practices, i.e. how 
health professionals can, through ‘involving themselves’ in 
understanding the experiences and concerns of patients, 
ensure that health services are suitably supportive of 
patients’ broader lives and health related practices.
The tradition of practice development that best represents 
this broader interpretation of involvement and which 
focuses on practices that extend well beyond clinical arenas 
is work on ‘supported self-management’. The fundamental 
insight that lies behind self-management approaches is 
the recognition that even those patients who happily rely 
upon clinical interventions and professional support will, 
nonetheless, have to spend the overwhelming majority of 
the time managing their health for themselves, possibly with 
the help of other lay carers. In addition, of course, many 
people deal with both short and long-term health-related 
concerns without seeking any help from professionals. 
Self-help groups and related community organisations and 
social movements have long recognised this fact and helped 
to give visibility to this kind of ‘lay’ expertise and work. If 
we start from this insight, the question then becomes, how 
can health service institutions and professionals operate in 
ways that recognise, ‘work with’ and actively support self-
management (rather than unwittingly undermining it). 
In the UK much pioneering work has been done to 
develop and trial patient self-management, and related 
educational and professional processes of patient support, 
by specialist agencies such as Diabetes UK. But the idea of 
self management itself does not entail a disease-oriented 
focus and is used as an organising idea for thinking about 
long-term illness agendas by agencies with a more open-
ended remit, perhaps most notably the ‘Expert Patient 
Programme’ which offers training and other services in 
different aspects of self management for both patients 
and professionals. One such agency that has made a very 
substantial contribution to conceptualising and trialling 
‘supported self-management’ and which aims to integrate 
the lessons of self-management into health services 
contexts, at scale, is the Health Foundation (http://www.
health.org.uk/), especially through ‘Co-Creating Health’ and 
related service improvement programmes.
Co-Creating Health, which builds upon international 
experience and research, is an exciting and crucially 
important initiative for patient involvement practice 
development in the UK NHS. This is because, through 
adopting a ‘whole systems’ approach and by seeking to 
embed the principles of self-management (and partnership 
working more generally) into a range of NHS contexts, 
it pays attention to the ‘nuts and bolts’ of improvement 
and seeks to bridge the gap between clinical and lay 
perspectives and roles by creating shared frameworks 
for collaborative working. Since 2007 Co-Creating 
Health has worked with eight NHS sites (in the areas 
of Diabetes, Depression, COPD and Musculoskeletal 
Pain) and helped to develop and implement tools and 
cultures that enable professionals and patients to work 
collaboratively on the agenda-setting, goal-setting and 
goal follow-up stages of supported self-management. This 
explicitly ‘holistic’ approach to practice development has 
meant working on three interconnected fronts at once: 
working with patients on self-management knowledge 
and skills, working with clinicians on developing advanced 
practice skills encompassing attitudes, knowledge and 
skills of collaborative working and, not least, working on 
service re-design to enable collaborative or ‘co-productive’ 
healthcare relationships. Some of the lessons of the 
programme, including some of the health-related benefits 
for participants have already been collated by the Health 
Foundation (see e.g. http://www.health.org.uk/publications/
snapshot-co-creating-health/) but the programme is 
on-going and broader evaluations, including an external 
evaluation (see Jones, 2010, Chapter 14) are in process. The 
obvious challenge to this kind of approach arises directly 
from its principal strength, i.e. because it takes a holistic 
‘system change’ approach it needs considerable broadly 
diffused effort and commitment to realise, and, for related 
reasons, is thus not easily susceptible to ‘gold standard’ 
evidence claims.
The ‘decision improvement’ approach and the ‘self-
management support’ approach to practice development 
are broadly complementary. Whereas the former aims 
to strengthen clinical decision-making the latter seeks to 
broaden conceptions of clinical work – to extend, and 
where necessary to erode, narrowly biomedical versions 
of health professionalism. Whereas the former zooms in 
on key clinical encounters in which important decisions 
have to be made, the latter zooms out to ask about care 
pathways and the broader systems and cultures of care 
and asks how these can be enhanced to support patients’ 
ongoing lives. Proponents of the two approaches also 
respond in different, but again complementary, ways to 
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the worries rehearsed in the previous section about ‘full 
blown’ versions of shared decision-making not necessarily 
being appropriate in, or practicable for, every context and 
case. Those in the former tradition strive to identify, and 
target effort towards, the most crucial decision junctures 
(where ‘preference-sensitive’ and ‘fateful’ decisions need 
to be made i.e. those which depend the most upon, and 
have the biggest impact upon, patient’s own values and 
biographies); whilst those in the latter tradition look to 
foster a variety of less structured models and styles of 
responsive and collaborative working for individuals, groups 
and communities.
Both of these contributions are vital to practice 
development in the area of medicines and patient 
involvement because, as discussed above, this is an area 
at the intersection of clinical and health-related practices. 
The focus both on prescribing decisions and on ‘adherence 
decisions’, and the close links between these things, mean 
that both ‘decision improvement’ and ‘self-management 
support’ are important. Indeed the area of medicines 
shows the need to combine the approaches very clearly: 
prescribing is itself often a process with an ongoing 
feedback loop between the patient and the professional. 
It is not just that a ‘correct’ prescribing decision needs to 
reflect the preferences and motivations of patients but 
also that prescribing may involve an extended process of 
decision-making, the ‘correctness’ of which will, in part, be 
informed by the compatibility of treatment regimes with 
patients’ preferences and lives. 
It is encouraging that there are influential traditions of 
practice development that provide conceptual and practical 
resources for, and real world examples of ‘stepping stones’ 
to, improved healthcare services and professionalism. But 
the underlying point of this section merits repetition: these 
different traditions of work may be broadly complementary 
but there are important differences in emphasis between 
them and anyone who has a commitment to reform in 
this area should be wary of fudging different examples 
together as if they all merely represent different means to 
a common end. Different models of practice development 
embody different visions of the purposes of healthcare 
services and different conceptions of the optimum roles 
and relations of professionals and patients. Both policy 
development and practice development depend upon 
a willingness for professionals and others to be able to 
openly and clearly reflect on, and debate, these different 
visions and conceptions. For example, this means a 
readiness to recognise and discuss the fact that ‘shared 
decision-making’ (much like ‘involvement’ itself, or ‘patient-
centredness’ – discussed in the previous section) does not 
have a single meaning but has a range of interpretations. 
There are a large number of versions of shared decision-
making – including narrower and broader versions - 
depending on a range of variables, in particular : (i) the 
kind of relationship that is envisaged between professional 
and patient (for example, how far should the professional 
see their role as about protecting the independence of 
the patient from professional judgement and values, or 
as about supporting co-deliberation about values as well 
as evidence? (discussed further in Cribb and Entwistle, 
2011);26 and (ii) about which ‘decisions’ fall within the scope 
of shared decision-making, for example, whether the focus 
is essentially on key clinical decisions (the typical focus 
of the ‘decision improvement’ tradition) or extends to 
‘systems re-thinking’ (one of the foci of the ‘supported self 
management’ tradition). As was said in the previous section 
in relation to the ‘tailoring’ of involvement, the important 
question is not whether something like shared decision-
making is a good thing – in some sense partnership models 
or collaborative ways of working will invariably be good 
things. The important question is about what versions 
of shared decision-making might be appropriate to (i.e. 
practicable in, and fulfilling the right purposes for) different 
circumstances and cases.
26 There are other ways of conceptualising the potential tensions inherent in models of shared decision-making. Finding the appropriate 
combination of, and balance between, ‘choice’ and ‘care’ in different cases (as discussed at the end of the previous section) is another way of 
formulating such tensions. Much depends upon exactly which rationale for shared decision-making is stressed. This has also been explored 
empirically in a number of studies; for example, Mendick et al. (2010) suggest that in some cases what ultimately matters to patients is whether 
they are sufficiently involved to feel that they ‘co-own’ the decision rather than that they are necessarily responsible for ‘co-making’ the decision (for 
a related discussion also see Edwards & Elwyn, 2006 and Entwistle and Watt, 2006).
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Improving involvement in 
prescribing and supporting 
adherence: from guidelines  
to practice
As explained in section 1, there is also a strong tradition 
of work on patient involvement specifically in relation to 
medicines, especially the work on ‘Concordance’ (one 
version of shared decision-making) originally fostered by 
the Royal Pharmaceutical Society. This work has included a 
substantial body of research and policy development and 
has resulted, for example, in the recent NICE guidelines 
on patient involvement in prescribing decisions and 
medicines adherence.27 These NICE guidelines (along 
with accompanying and associated developments; for 
example, the NPC Plus competency framework (Clyne, 
Granby & Picton, 2007) provide a very substantial, and 
well-supported, platform for practice development in the 
area. They authoritatively summarise the broad rationale, 
principles and characteristics of good practice. Nonetheless, 
for all the reasons discussed above, there remain 
challenging questions about how best to translate these 
guidelines into actual practice so as to ensure that they 
have the level of impact that they deserve. This section will 
briefly rehearse some of these questions and offer some 
beginnings of a response to them. The core issues have all 
been fully discussed above and will only be briefly alluded 
to here. They concern the challenge of translating between 
general guidance and very particular circumstances and 
cases (and the possibilities afforded by specific contexts); 
the need for practical wisdom in recognising and managing 
the contestability of ideals and purposes; and the need 
to address ‘nuts and bolts’ factors, i.e. finding real world 
‘stepping stones’ to improvement, without which guidelines 
inevitably remain detached from practice.
Given all the complexities of healthcare change, broad 
guidelines, such as the NICE guidelines, can help steer 
and support practice development. It is impossible to do 
justice to these guidelines here, not least because the full 
version runs to 364 pages (see http://guidance.nice.org.uk/
CG76). They draw upon considerable research evidence 
to generate guidance for prescribers. In essence, they 
offer advice on how to manage both intentional non-
adherence (patients choosing not to take their medicines) 
and unintentional non-adherence (patients not taking 
medicines because of other factors). In addition to sections 
on medicines reviews and professional-to-professional 
communication (see below) the advice focuses on 
enhanced communication between clinicians and patients, 
and puts particular emphasis on the greater involvement 
of patients in medicines decision-making. It includes what 
might be seen as a checklist of communication ‘tips’ and 
techniques (for example, inviting questions  from patients 
and asking them open-ended questions). However, alongside 
and, as it were, ‘beneath’ this attention to communication 
skills narrowly construed, is a clear concern with fostering a 
set of attitudes and values among prescribers. 
Prescribers are not only reminded that ‘patients have a 
right to decide not to take a medicine’ (assuming they have 
‘capacity’) but are encouraged, more generally, to accept 
‘that patients may have different views from healthcare 
professionals about risks, benefits and side effects’ 
(NICE, 2009, p8-12).28 The importance of prescribers 
being adaptable and responsive to patients is stressed, 
and advice is given about ‘tailoring’ communication to 
individual patients (in terms of content, style and the level 
of involvement wanted), attending to patients’ concerns 
and providing opportunities for patients to express their 
perspectives and views. Last, but not least, all of this is to 
be accomplished in a ‘non-judgemental’ spirit. In short, 
although it is not signposted in these terms, what is being 
advocated is not merely more technically effective means of 
transferring or transacting information about medicines, but 
forms of relationship that are more open, richer and more 
respectful towards patients.
The NICE guidelines, and the body of work that supports 
them, attend both to involvement in prescribing and 
support for adherence and, therefore, they reflect many 
elements of the two approaches to practice development 
and shared decision-making just discussed – an approach 
centred on enhancing the quality of key clinical decisions 
and an approach centred on strengthening and broadening 
services for patient support. However, here as elsewhere, it 
27 It is noteworthy that right until the final draft these guidelines were labelled as ‘concordance’ rather than ‘adherence’ guidelines, and they very 
much embody the philosophy of the concordance work that informed them.
28 More generally, those people who have researched intentional non-adherence typically wish to help prescribers understand that it is often quite 
rational. See, for example, DeMarco & Stewart (2010).
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is important to acknowledge that there are important issues 
of interpretation and relative emphasis that arise when aiming 
to apply the guidelines. These issues of interpretation can be 
briefly illustrated here. For example, and sticking to a very 
general level, the guidelines embody two broad purposes: 
(a) improving adherence; and (b) increasing partnership 
working in prescribing decisions. They are based on the 
(largely) plausible premise that (a) and (b) are compatible 
and indeed that (b) supports (a). However in practice there 
will sometimes be tensions between the practical strategies 
one would emphasise if prioritising (a) (roughly involvement 
components 2 to 4 inclusive, listed above in section 1) or 
(b) (roughly components 4 to 6) inclusive (see section 1)), 
that is, situations where one has to decide what to do when 
it seems that more emphasis on exploring option sets and 
promoting shared decision-making may, for a particular 
patient, risk undermining the adherence benefits to be gained 
by a narrower focus on information sharing and responding 
to patients’ questions and concerns. 
This one example is enough to indicate that there is a limit as 
to how far even these very important and helpful guidelines 
can define and determine good practice in specific cases. 
Guidelines can help inform but they cannot replace context-
responsive professional judgement. Nor can guidelines 
completely circumvent wider debates about which policy 
ideals and purposes we should, in various contexts, be aiming 
to enact. Indeed it is arguable that the body of work that 
informs the NICE guidelines more fully reflects the ‘decision 
improvement’ tradition of practice development than the 
‘service re-thinking’ tradition – especially as manifest in 
something like the Co-Creating Health approach with its 
stress on broadening the orientation of health services and 
actively fostering collaborative working through system and 
cultural change. These more holistic and ‘radical’ themes are 
relatively neglected in the academic and policy literatures 
on medicines adherence and thus have the potential to 
significantly enhance the available repertoire for improving 
patient involvement in the area of medicines choices.
When it comes to finding and putting in place appropriate 
‘stepping stones’ to translate guidelines into practice 
comparatively little can be settled at a general level. Suitable 
strategies will depend upon a conception of ideals and 
purposes and this, in turn, will partly depend upon what is 
appropriate (and practicable) in relation to different settings, 
treatments and conditions and in relation to different 
professional and patient groups. Given the pervasive ethical 
and practical complications rehearsed in the previous section 
it is simply a mistake to assume that any such guidelines could 
be directly and straightforwardly implemented anywhere 
and everywhere. Nonetheless, it is possible to summarise a 
few broad areas of improvement that need to be addressed, 
many of which are explicitly or implicitly signalled in the NICE 
guidelines themselves.29 They relate to what might be thought 
of as the essential preconditions of patient involvement 
in relation to medicines, without which none of the more 
specific stepping stones to change can be put in place.
1. RECORDING AND PROFESSIONAL 
COMMUNICATION
Effective systems for recording and communicating medicines 
regimes are essential because patients typically travel with 
their medicines within and across different institutions 
and sectors and see a range of health professionals. It is 
important that the many professionals who may be called 
upon to discuss medicines have access to good medicines 
information including recorded reasons for specific 
prescribing decisions. Unless we can achieve high levels of 
successful professional-to-professional communication in 
this area, it is unrealistic to push for higher levels of patient 
involvement because patient involvement models rest on the 
assumption of informed professionals.
2. MEDICINES REVIEWING 
NICE, and others, have stressed the fundamental importance 
of regular opportunities for medicines regimes to be 
reviewed. Routine medicines review systems are crucial 
for following up on the use of prescribed medicines and 
provide opportunities not only to support adherence but 
to revisit prescribing decisions, in some cases to enable 
more shared decision-making and more broadly to provide 
patient education and enhance the patient experience.30 
29 The points summarised here also owe much to the many professionals who generously shared their experiences and expertise in recent 
fieldwork, some of which informed the examples offered in Appendix 1.
30 Medication review can be implemented in a range of settings and by a range of professionals and the development and evaluation of 
new initiatives in this area is crucial. The introduction of the ‘New Medicine Service’ alongside ‘Medicine Use Reviews’ into the NHS community 
pharmacy contract is a potentially important development for supporting patient education and adherence agendas as well as consolidating and 
extending the role of community pharmacists in this area.
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For medicines review to be effective and meaningful to 
patients it needs to be led by responsive professionals 
(ready to move outside of protocols) and ideally be given 
enough time and space rather than simply slotted into other 
busy practice activities and schedules. In the medium to 
long term, the goal should be to gradually build institutional 
climates where (a) patients are increasingly used to the 
idea of and comfortable with discussing their medicines 
with professionals, and (b) some professionals who have 
the resources (knowledge and skills) to do so are available 
for such conversations even outside of scheduled review 
events.31 Once again, richer and more complex forms 
of patient involvement can only really be built on the 
foundation of suitably willing and prepared patients   
and professionals.
3. CREATING AND EXTENDING COMMUNICATION 
SPACES AND PROFESSIONAL ‘SCRIPTS’ 
Arguably the most crucial building block for strengthening 
patient involvement in practice is the creation of conditions 
for genuine professional-patient communication. This is 
not an easy matter32 and often involves carving out new 
or special spaces and times for communication either by 
changing the ‘scripts’ of consultations or by creating new 
kinds of appointments. These extended, and ideally more 
collaborative, kinds of clinical encounters can be usefully 
complemented by looking for broader possibilities for 
interactions between professionals and patients. These 
include non-clinical (and therefore sometimes more ‘natural’ 
and equal) encounters through social events, patient 
organised groups and/or professionally organised seminars 
and workshops that involve patients. Unless time and 
effort goes into establishing the possibilities for these new 
styles of communication – whether these just amount to a 
small extension to practice or to something more radical - 
nothing can fundamentally change.
4. BUILDING LOCAL TOOLS AND TACTICS 
In some cases there may be ‘off the peg’ solutions to 
involvement challenges but more often than not these 
challenges can only be met by imaginatively tailoring 
(developing or adapting) tools and professional tactics 
to specific needs and purposes. In the area of patient 
involvement, especially in shared-decision making or 
concordance work, there has been a tendency to focus 
on specific kinds of ‘tools’, and especially upon ‘decision 
aids’. These can be useful but they do have some potential 
limitations – they take a good deal of time to develop 
and trial and are not always easy to apply in specific 
circumstances. Nonetheless when ‘owned by’/ ‘adopted 
by’ services they can support involvement as can a range 
of other patient support tools – for example, suitably 
targeted information sheets or web resources, agenda-
setting tools, planning and agreement tools, record cards. 
There are also other more low-key practical devices which 
can be very important to get conversations going – for 
example, pictures of tablets, or the actual use of tablets in 
consultations so that medicines taking can be discussed in 
very concrete terms. 
There is substantial expertise, amongst pharmacists and 
amongst others who use medicines in specific, often 
specialised, contexts, about how various medicines do and 
do not ‘fit into’ different patients’ lives. And there is a wealth 
of good practice available about technical matters - such 
as dosing regimens, routes of administration, packaging 
and access to medicines and repeat prescriptions – that 
can significantly enhance the quality of prescribing and 
rates of informed adherence. However there is room for 
considerable improvement in ensuring that institutions 
identify effective procedures for spreading and embedding 
this expertise in routine practice. 
31 The recent Royal College of Physicians report (N=1, Why people matter in medicines, 2011) stresses the need for doctors and others with 
responsibility for communicating about medicines (in reviews and elsewhere) both to work in partnership with pharmacists and also to be 
supported to develop their own pharmacological education – stating that, for example, ‘[e]very GP practice in the country should have access 
to a local pharmacist adviser, to whom they can refer patients with medication problems, and who can be used as a source of advice for both 
patients and GPs on medication related issues’ (p8); and that ‘pharmacists have a very good pharmacological education …. We need to make 
sure that all future prescribers – including doctors and nurses – have this knowledge in order to deliver better patient care. Only in this way will 
prescribers have the ability to communicate information about medicines. ... [T]his ability is fundamental, and underpins not only safe practice but 
also adequacy in partnering patients and the public in understanding the part that medicines can play in their lives’ (p7). Certainly, thought needs 
to be given to the best balance between drawing upon specialist medicines knowledge (irrespective of profession) and spreading knowledge more 
widely, but both are clearly important.
32 Please see Appendix 1 for a much fuller discussion of this theme.
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What these practical tools and tactics, and other good 
practice methods, have in common is that they provide 
manifest evidence of professionals taking an active interest 
in the patient’s point of view on what is being discussed 
and decided. Just as tools need to be developed and 
adapted for the immediate job at hand, so the related 
communication strategies and relationship styles employed 
will only fully work if they organically arise from, and 
appropriately reflect, local circumstances.
5. INSTITUTIONAL AND COLLEGIAL LEADERSHIP 
The kinds of change that are demanded by the new policy 
orthodoxy of involvement, and endorsed in this paper, 
depend upon strong professional leadership at both 
national and institutional levels. Such leadership can help 
to provide clarity about basic principles and standards 
but also link this with the encouragement of debates 
about competing visions and purposes and about practice 
dilemmas. The resulting educational and collegial initiatives 
need to encompass, but go well beyond, an understanding 
of models and techniques and foster a lively interest in, and 
a sense of responsibility for, context-responsive practical 
wisdom. They should also help to establish some ‘bottom 
up’ mechanisms for identifying, monitoring and sharing good 
practice (including conversations about when, where and 
how it can be adapted for other settings and services) and 
encourage the trialling of new approaches. Institutional and 
professional leadership is also essential in fostering, and 
responding to, broader forms of collective involvement 
in healthcare planning. The interest in the individual 
patient’s voice has often been advanced by broader social 
movements and organisations, and wider attempts at 
developing forms of civic engagement in healthcare or the 
‘co-production’ of services can help to substantially enrich 
models of professionalism.33 
33 This commitment to broader and deeper levels of collective involvement, and to related but wider notions of democratic accountability, also 
help to answer the legitimate worries of critics who view scepticism about managerial forms of accountability purely as a form of professional self-
protection. Also see, for example, Doherty & Mendenhall (2006).
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4. CONCLUDING DISCUSSION
There is certainly an ‘ethical imperative’ to involve patients 
in treatment decisions. At the same time there are enough 
ethical complications to mean that ‘practical wisdom’ 
needs to be employed in the tailoring of involvement 
to circumstances and cases. The ‘quality imperative’ is 
equally undeniable – unless ‘compatibility with patients 
preferences’ is included in our notions of decision quality 
then we operate with limited, misguided, and in most cases 
simply indefensible notions of quality. Nonetheless, our 
conceptions of ‘quality’ also include other dimensions of 
concern that may sometimes limit the scope for individual 
patient involvement, including, for example, patient 
protection concerns, or public health concerns. Finally, 
as signalled in the opening section, the arguments for an 
‘economic imperative’ also have relevance but are more 
obviously contestable. Following the discussion above, the 
reasons for this contestability should be clearer. Whilst 
there is a good case for arguing that patient involvement 
is cost-effective because patients’ informed choices will 
generally lead to fewer ‘unwanted’ interventions and 
higher levels of adherence with ‘wanted’ interventions; this 
case needs to be qualified in two key respects. First, it is 
obviously important that any cost savings are treated as 
a side-effect of better involvement policies rather than a 
direct driver in specific contexts – because the latter risks 
distorting the proper processes of delivering carefully 
tailored involvement practices. Second, the overall cost-
related benefits may be limited because: (a) after a period 
of improved involvement, and the ‘involvement cost-
effectiveness premium’ derived from it, there is no reason 
to imagine further levels of involvement would yield still 
further cost containment; and (b) perhaps even more 
significant – the provision of carefully tailored involvement 
practices itself has significant cost implications and it would 
be wise to re-invest some of the potential savings from 
revised treatment choices into the broader development 
and dissemination of good practice in this area.
Overall the arguments for patient involvement in 
treatment choices and for shared decision-making (in 
various versions) are certainly strong enough to justify the 
policy orthodoxy summarised at the start. The practical 
and ethical complexities rehearsed in this paper do not 
provide any grounds for dropping the accompanying sense 
of imperative or for lessening the enthusiasm or zeal 
of involvement proponents. However, they do provide 
grounds for caution about the generalised ways in which 
involvement is sometimes ‘pushed’ by, or interpreted in, 
policy interventions. Approaches to policy change in this 
area need themselves to reflect, protect and support the 
values that motivate the desired change.
Finally, there is no prospect of closing the gap between 
the policy orthodoxy and routine practice unless we learn 
from experience and expertise ‘on the ground’. Both 
collegial leadership and educational change depend upon 
reducing the emphasis on abstract models and labels and 
increasing our attention to the practical and philosophical 
complications that have to be negotiated in day-to day 
clinical work. To help this process of reorientation, two 
appendices on these themes are offered to support the 
identification of, and education about, more ‘realistic’ 
approaches to policy change and practice development.
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Appendix 1 
LESSONS FROM PROFESSIONAL PRACTICE
This appendix explores and illustrates the translation 
of ideas about involvement into actual involvement 
practices by drawing on the insights of professionals with 
experience of patient involvement practices including 
more collaborative forms of working.34 The value of 
looking at these examples is not only that they give a 
broadly optimistic message (i.e. by showing that, and 
how, involvement practices are possible) but also that 
they indicate the range of difficulties that have to be 
overcome to enact them. Talking about ‘difficulties’ is not 
intended to set a negative or pessimistic tone but rather 
a realistic one. It is important to have a realistic sense of 
the difficulties that have to be overcome if we want to 
change practice. Otherwise it is too easy to talk as if a 
simple, pain-free, cost-free change of model or mind-set 
can effect change. The difficulties here are largely practical 
ones - the professional, technical and organisational 
burdens of, and barriers to, change. But caught up in this 
mix are what might be thought of as ethical burdens and 
barriers. That is to say, changes in practice will rarely be 
non-contentious. There will almost inevitably be a range of 
considerations which point in different directions or which 
suggest different emphases according to what principles 
or values we foreground. Negotiating change thus requires 
some consideration of ethical balancing acts. These will not 
be considered in any depth in the account that follows, 
but some of them will be signalled in passing (they are 
summarised in Appendix 2 and discussed further in the 
main body of the paper and in work cited there).
The insights drawn upon here are based on informal 
conversations about involvement with about 75 interested 
professionals and on semi-structured qualitative interviews 
with 25 professionals who were closely involved in 
developing or enacting involvement practices, or at least 
work in areas where involvement practices had been 
‘normalised’. (The conversations and interviews took place 
between January 2009 and September 2010.) 
What is presented here is not a conventional analysis of 
qualitative data. Rather it is an illustrative summary of some 
of the lessons from these conversations and interviews 
using the professionals’ own words extensively. Although 
the ambition is to provide a relatively systematic and 
rigorous account and to reflect the data carefully, there is 
no explicit emphasis here on establishing validity, still less 
on representativeness; rather the core ambition is simply to 
illustrate possibilities, and prompt discussion and reflection, 
through the presentation of some examples. Where italics 
are used, the quotes are taken directly from the tape-
recorded and transcribed qualitative interviews.
The overall analysis highlighted the number of different 
factors that need to be considered when enacting 
involvement practice. Here, for presentational purposes, 
discussion of these has been organised around the eight 
different components of patient involvement practices 
identified in the main report: (1) creating the conditions 
for communication; (2) informing and educating patients; 
(3) promoting self management; (4) being responsive 
to patient perspectives; (5) joint agenda-setting; (6) 
joint decision-making; (7) relationship building; and (8) 
re-working relationships and systems. The components 
cannot be separated out from one another in reality, but 
are being abstracted out here to help focus attention on 
some of the different strands of involvement work. All, 
or nearly all, of these components are present, albeit on 
some interpretation and to a greater or lesser degree, in 
each of the examples of patient involvement practices 
used here. However different examples will be used 
to focus in on each of these components and illustrate 
what they can involve in practice. The services referred 
to (and/or similar kinds of services) have been audited 
and evaluated extensively but that is not the focus of the 
current discussion. The purpose here is simply to illustrate 
and discuss the practices so as to help share a better 
understanding of the nature of patient involvement.
34 There is, of course (at least) as much to learn from the experiences and insights of patients who have engaged in collaborative working. It is 
simply that this study focused upon learning from the experience of professionals.
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It would be possible to illustrate all eight components in 
relation to some paradigm services. For example, diabetes 
care is an area where a lot of innovations in partnership 
working have arisen and been formalised. There are 
recognised programmes for encouraging shared care 
planning and decision-making and self-management and 
this has entailed new service models and philosophies and 
changes to the professional development and practices of 
individual practitioners and multi-disciplinary teams. For 
that reason, five professionals with considerable experience 
of these changes were interviewed. However, a range of 
examples are used here to illustrate the components of 
patient involvement and to reflect practices that are not 
necessarily as widely recognised, formalised and embedded 
across institutions as the diabetes practices and models, 
including some that have arisen from and are emerging 
from local teams and from the philosophies and practices 
of individual professionals. Here each component will be 
illustrated through one or two examples. As the account 
unfolds, some of the tensions, including the ethical tensions, 
between these components will be illustrated. 
The use of examples gives rise to questions about if and 
why these cases are different from other cases, or from 
one another, and whether what might be relatively easy in 
one situation may be very difficult or near impossible in 
others. But respondents were often quite keen to assert 
that the broad principles underlying their work were of 
general relevance and so at the very least this suggests we 
should be ready to reflect on the key differences between 
cases and to ask whether our first thoughts about the 
appropriateness of the different components to different 
cases are really justified. There may well be sound reasons 
for our judgements that cases are different in important 
respects but, on other occasions, these judgements may 
simply reflect habitual thinking.
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Example 1 
SUPPORTING INFORMED ADHERENCE WITH BLOOD PRESSURE 
TREATMENT
In the service drawn upon here specialist nurses work with 
new patients and patients who have not achieved good 
outcomes with hypertension medication, often because 
of non-adherence or intermittent adherence. This involves 
listening to, and extended discussions with, the patients (and 
carers), prescribing medicines and making adjustments to 
medication regimes to achieve more ‘informed adherence’ 
or ‘concordance’ between prescribers and patients.
COMPONENT 1. CREATING THE CONDITIONS 
FOR COMMUNICATION
Communication does not come about effortlessly. It 
requires the right levels and kinds of time, space, skills, 
attitudes and trust, and all of these things require significant 
investment of thought and effort if not financial resources. 
The clinical nurse specialists who provide this service 
stressed the importance, and challenges, of creating a space 
of trust in which patients and professionals could exchange 
perspectives ‘openly’ with one another. Their accounts 
underline two of the fundamental factors that are essential 
to understanding the challenge of patient involvement: first, 
patients and professionals are not always on the ‘same page’ 
or on the ‘same track’; second, it is not always easy, for a 
variety of reasons, for patients and professionals to talk to 
one another.
The nurses begin from the recognition that ‘patient 
involvement’ is not really ‘an option’ in relation to use of 
medicines, because it is a necessity:
The patient’s in charge. That the patient, it’s their condition, 
it’s their tablets and you know, they choose, I can’t make 
anybody do anything. So, you know, all you can do is explain 
and offer and suggest and […] give them the information so 
they can make an informed choice. 
The patient [is] an integral part of the patient management 
in hypertension, because it’s a chronic condition […] it’s 
something that has just to be managed, so unless they are 
part of the planning and implementing, it tends not to work. 
We want them to take part, you know, it’s not a question of 
saying, of advising – although we give advice – it’s a question 
of actively involving them in planning their care. 
However although the ‘theory’ (providing information and 
support to encourage patient involvement and decision-
making) is relatively easy to summarise, the practice is very 
demanding indeed. This is not least because both parties are 
often used to different communication climates and norms 
in which patients can be more passive. And these norms 
also enable patients to keep things to themselves, which 
they might like to do:
They’re quite often passive, used to being passive, they’re 
used to being passive. And so, I’m trying to get to change 
that into... active […]. What I’m, sort of, desperate to get 
them to do is to take part.
They’re not used to this sort of dialogue, the doctor’s in 
charge or the nurse is in charge, they’re the boss and the 
patient then does what they’re, appears to do what they’re 
told. So they like to please, they like to look as if they’re doing, 
what they’re doing and they’ll go, you know, and not do it. It’s 
a huge frustration!
In addition to other aspects of clinical expertise these 
nurses have had to develop hard won professional 
expertise in creating the conditions for, and practising, 
what they call ‘an open communication dialogue’. Above 
all else this means creating an atmosphere and a kind of 
relationship in which the patient feels able to be honest:
I’m not, you know, I’m not a headmaster or anything like that, I 
want her to feel that she can actually tell me what’s going on 
with her tablets and how she feels about them.
My role is to make life better for them when they, when they 
come to us, by letting them tell me what’s been going on in 
their lives with their tablet-taking and let them get back in 
control in any way […] that I can.
I’m not here to judge you, I’m not the doctor and, you know, I’m 
not in authority, I don’t wear a uniform so […] I’d like to think 
that I don’t look a threatening person to them. And, so, I’ve said 
to her, ‘look, go to all your cupboards and empty everything out 
that you’ve got and I’ll have them all and I’ll dispose of them 
and then we can just start again and start afresh.’ 
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And it’s done in a smile, yeah, it’s done in a sort of a half-smile, 
you know, we, you sort of have a bit of a laugh about it… 
This approach takes time, with consultations routinely lasting 
30 to 45 minutes and sometimes more. It is clear from 
this alone that it is an approach that relies on transactions 
which are ‘different in kind’ to many professional-patient 
transactions such that the approach could not be 
straightforwardly translated into them. However, even with 
this amount of time and the self consciously friendly and 
non-judgemental approach, some patients will not ‘open up’:
This is where we’re at, what’s gone on before, you know, 
whatever the reasons, but, if I’ve said something that makes 
you change your mind, and you will start taking your tablets, 
that’s fine. But, you know, I […] should think the greatest 
psychotherapist can’t get really to the bottom [of it].
Sometimes you’ll never get them to, you know, they’re so 
intransigent that they won’t open up. 
If you don’t want to take your tablets don’t take them! Just 
tell us! I mean, I don’t, you know, I really don’t care! Just don’t 
let’s give you any more tablets. 
Through the palpable sense of frustration contained in parts 
of these accounts the ‘gap’ between the clinical world and the 
patient world is made manifest. Patient involvement practices 
are about the process of closing this gap in a variety of ways.
When dialogue can be established, a whole range of things 
become possible. Professionals can learn about the patient’s 
life, perspectives and values and there is also an opportunity 
for providing information to, or educating, patients. Next 
the focus will be upon the second of these but, of course, 
the ‘two directions’ of communication cannot be separated       
out in practice.
COMPONENT 2. INFORMING AND EDUCATING 
PATIENTS
Patient education about medicines starts from a detailed 
engagement with what individual patients already do, and 
understand, in relation to their medicines:
We ask the patients to bring all their tablets with them and 
we go through the tablets with them. 
Anything on their prescription sheet can be inaccurate and so 
the only treatment the patient is having is what they put in 
their mouth that morning. […] So, it may say, ‘take 2 a day’ 
on the box but in fact the patient is only taking one a day. So, 
that’s not, it’s not wrong, it’s just what’s the patient’s doing. 
Eliciting information about medicines use from patients 
is sometimes very difficult but the emphasis on creating 
a non-judgemental and open encounter means that it is 
often possible to get a clearer picture of the way patients 
think about and use their medicines, including why they 
sometimes don’t like their medicines or use them. This 
means that the nurses have to be sensitive to a range of 
biographical and cultural factors that might influence a 
patient’s beliefs and practices. On some occasions this will 
include addressing misconceptions about, or a simple lack 
of understanding of, conditions and treatments. In many 
cases patients will have inherently complex and confusing 
medicines regimes which need to be looked at in the 
round and, perhaps, consolidated. The opportunity to get 
an overview from patients does not just facilitate education 
about medicines but is set in the context of a broader 
health promotion and lifestyle approach:
So then I started from the beginning, to explain to her what, 
her blood pressure was, why we treat it, what the problems 
are, what are the dangers of high blood pressure and how we 
treat it and how the tablets work. And that’s just very simply 
describing it as, that you take the tablets, and they only last 
for 24 hours and then they’re washed out of your system and 
your blood pressure goes back up. And so I spend quite a 
long time explaining that this doesn’t treat the blood pressure 
it just bring it down and protects the organs of the body. 
And, that that’s why a tablet is required each day. And I put 
it similar to the oral contraceptive pill, if you don’t take a pill 
every day then you might get pregnant.
A lot of our patients are, may be diabetic, or they’ve got 
arthritis, or they’ve go[t], you know, lots of other things wrong 
with them and they’re on maybe ten drugs? Ten-twelve drugs, 
maybe more. And so, that is a good time to go through their 
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tablets and, say, if they’re diabetic, you know, explain why 
those are so important to take, you know, at certain times 
of the day or not, and then... Some tablets are perhaps less 
important, you know, they’re, I think, you’ll find that an awful 
lot of people are overwhelmed by the number of drugs that 
they’re on. And that’s a real big cause of not taking them. 
Because they don’t know what makes them feel rotten, so if 
they don’t take them, then, you know, that’s their answer to it, 
and I’m there to provide ways of cutting them down perhaps, 
or putting them on slow release. […] So, there’s lots of ways 
that you can show them that you are on their side and you 
want, whatever they’re taking, to be taken accurately.
And part of that package is taking the medicines or losing 
the weight or doing more exercise, it’s a sort of triangle of 
things that are in their […] control. And how we can find a 
modus operandi that’s going to work for them. […] So it’s not 
just the hypertension, […] it’s the whole person.
This kind of responsive and broad-ranging approach to 
patient education is not only time-demanding but also 
demands the development of considerable professional 
skills, amongst which ‘listening skills’ were most strongly 
emphasised along with a readiness to cope with being 
‘challenged’ by patients:
People who feel they’ve been listened to, it’s the most 
fundamental thing, actually, if I’m going to say anything, 
[…] and reflect back on what the person has said, so 
you’ve understood […] what’s going on here. And you give 
the information in terms that they can understand, and… 
personal. You know, not just, ‘here’s a leaflet’. A leaflet can 
add to that. And in the dialogue of listening and giving them 
information, being open to the questioning during the time, 
and at the end of the consultation, you know, making sure 
that there are no further questions they want to ask. 
When you’re starting off that’s quite nerve-wracking, but, 
there’s noth[ing], you know, you can challenge me on 
anything now... […] That’s quite hard for health professionals 
to take, you know, take the challenges, because [you] can’t 
possibly know everything. […] But yes, it doesn’t bother me 
now, but it was difficult in the beginning, which is, you know, 
why perhaps these dialogues are difficult for other people 
to do.
But if patients are encouraged to be more open and 
‘active’, this does entail different approaches and skills 
for health professionals who not only have to be able to 
listen but also have to be able to deal constructively with 
challenges. The attitudes and skills that relate to one person 
‘acting upon’ another are different from the attitudes and 
skills that are appropriate when two people are properly 
‘inter-acting’. 
It is not just a question of simply ‘closing the gap’, as 
referred to above; professionals have to be ready to 
acknowledge that there is a gap, or even a clash, between 
the two points of view, but still find ways forward that 
aspire to something like ‘partnership working’ without 
denying the reality of any such gap or clash. This shift 
towards a ‘dual agency’ assumption connects to a pervasive 
tension between the different aims of the educational 
components of interventions (indeed of all aspects of 
interventions) – tensions between the ‘empowerment’ and 
‘prevention’ goals of health education; or, in more general 
terms, between handing over control and trying to steer 
people in the direction of looking after their health. These 
different aims are encapsulated in these two comments 
from the same respondent:
My role is to make life better for them […] when they come 
to us, by letting them tell me what’s been going on in their 
lives with their tablet-taking and let them get back in control 
in any way […] that I can. 
What am I trying to do here? I’m trying to prevent heart 
attacks, strokes, kidney disease, vascular disease, dementia,  
and eye damage. 
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Example 2 
SUPPORTING PATIENT MANAGEMENT OF DIABETES
As noted above, diabetes care is one of the areas that has 
led the way in terms of patient involvement practices. There 
has been a widespread recognition – supported by the 
work of Diabetes UK – that the effective management of 
diabetes depends upon fostering new healthcare ‘scripts’. 
In a nutshell, this entails patients not only taking an active 
part in, and responsibility for, the day-to-day monitoring 
and treatment of their condition but for them also being 
enabled and encouraged to take a more active and central 
part in consultations, care planning and teamwork. In turn, 
this requires new ‘professional scripts’ as professionals 
need to learn how to respond to, and put in place, 
systems to support patient agency and perspectives. This 
section  draws on conversations and interviews with nurse 
specialists and General Practitioners with a particular 
interest in these shifts.
COMPONENT 3. PROMOTING SELF-MANAGEMENT
A move towards more widespread and more effective 
self-management involves work on every facet of the 
healthcare system and a reorientation in the health service:
to support people in their wellness not their illness. Or both I 
suppose in an acute situation. 
This means putting in place educational opportunities 
for patients and professionals, developing shared models 
of working across sectors and settings, changing the 
culture of teams and developing practices of, and tools 
to support, patient agenda-setting and decision-making. In 
this context, patient education becomes a very significant 
dimension of healthcare and much more than a strand in 
professional consultations. This allows not only for a shift in 
scale but also for more breadth of educational approaches, 
philosophies and aims which can, for example, include 
structured courses and peer-led group work designed to 
support ‘ownership’ of the issues: 
I think it’s about a six-week course so it’s really just giving 
them the skills to be able to start self-managing. And also 
to be able to come to consultations, and it not being on our 
terms. So our part of that would be, you know, when people 
come, […] to give them the opportunity to think about their 
agenda before they actually come. 
Because we know what’s important to us, but unless it’s 
important to them, then it’s really of no value. Because in 
diabetes care, you know, it is all about self-management. It’s 
about them managing their disease for three hundred and 
fifty odd days a year. And us just tinkering now and again 
when they come in and saying, ‘what have you thought 
about this or that?’ So, it’s very important that they […] 
identify what is important to them. 
It’s encouraging the patients to go on courses to help them 
how [sic] to manage the situation better, helping them to 
self-manage it, looking at professionals going on another 
course to help us to... change the way that we’ve always 
worked, or possibly have always worked, in a very medical 
management of diabetes. And encouraging patients to be 
more involved in their care.
The corresponding role of the health professional then 
needs to become less prescriptive and to find ways of 
engaging with, responding to and enabling patient   
self-management:
And that’s very much changes in diabetes management. 
Because, whereas before we would have been quite 
prescriptive about what to eat and when to eat it and how 
much to eat, I think there’s a realisation that really wasn’t 
working. You know, people were saying, ‘yes, yes, yes’, walking 
out of the door, and do completely what they’d already been 
doing for fifty-sixty years! So… we’ve got a dietician attached 
to the team and she will see, you know, them. And obv[iously], 
if they are eating something that is very high in sugar, then 
she will actually provide alternatives as opposed to say, ‘don’t 
do that.’ You know, so she will say, ‘a better choice would be...’.
So they say, ‘well, ok, from everything that I’ve heard, you 
know, I’m going to try to do something.’ And we then, we don’t 
tell them what it is in any way but we […] go through how 
they would actually really bring that action plan right the way 
down. So rather than saying, ‘ok, so I’m gonna lose weight,’ 
well, it’s about, ‘so, you really want to lose weight but how 
are you going to do [it] and what exactly are you going to do 
every day? And when you reach a barrier on that, how are you 
gonna address it?’ 
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Professionals stressed the importance of, and the difficulty 
of establishing, a common commitment to self-management 
across teams and sectors so that pathways can be planned 
with some consistency of approach as well as some 
continuity in relationships. Effective team working was 
seen as essential not only for reasons of consistency and 
continuity but to fully realise the respective contributions of 
different specialisms:
So that it’s important that we use the same sort of skills and 
processes to discuss with a patient, because if we don’t, the 
patient thinks two different things are happening […] and, 
you know, it’s disconnected. ‘Ah, but the hospital told me this 
and the GP is sort of doing this!’ […] And if you don’t have 
the same message in the same way, it’s very hard for people 
to understand what decision they want to make. 
Because we all bring something very different to the table. 
And, as a nurse, you know, I may be looking at the practical 
issues. You know, we may say, some people with diabetes, 
well yes they should be on a certain insulin regime, but I may 
then say, ‘but, actually, they haven’t got the dexterity and so 
we would need to use a certain type of pen.’ Whereas the 
dietician may say, ‘yeah, but if they act slightly differently 
then they may not need that sort of insulin’, and the 
consultant may say, ‘well, why don’t we take them off insulin 
completely?’ So, we just all bring different, because we’re all 
coming from a different starting place. We have different 
knowledge bases and I think that’s why, you know, we all 
bring something different.
This emphasis on the importance, and challenge, of 
reshaping the whole system and professional environment 
that patients encounter extends, for example, to the crucial 
role of administrators and receptionists and their skills   
and attitudes:
I think the first thing that... the first contact they’re going to 
have is with the receptionist, and that needs to be a good 
contact to set the scene. 
We have a lot of receptionists that are now involved in 
diabetes care. And there are whole systems in practice 
around encouraging people to come to their appointment. If 
a patient gets tons of letters saying, ‘look, you haven’t come 
to your appointments, your eyes are gonna fall out, or, you 
know, your foot is gonna drop off ’, they’re not gonna come! 
So it’s about saying to a receptionist, you know, when you’re 
encouraging people to turn up for their appointment, you 
know, have something that will help them to engage and 
help them to turn up. Because if they think they’re gonna 
come and they’re gonna be told off, they won’t come!! 
One important aspect of self-management is an increased 
role for the patient within the consultation not only in 
agenda-setting but also in decision-making (discussed 
further in the next example). A constantly repeated 
message from all the professionals consulted was that not 
all patients seek or accept the responsibility for making 
decisions or ‘choices’. It was also pointed out quite often 
that there are not always meaningful clinical choices 
available. But when there are such choices these can be 
shared with the patient who will then at least have the 
option of contributing to and owning the decision that 
they are going to have to enact and live with. And where 
the possibility of this kind of involvement exists, then, in the 
experience of these professionals, there is a much greater 
likelihood of decisions being actually followed through and 
reviewed effectively:
Then I might say, ‘look, here are the options, so you could try 
insulin therapy, we could try adding in a third tablet or we 
could try keeping things as they are.’ And you will say the 
benefits and the drawbacks to all of them. So with insulin 
it is about blood glucose monitoring and injecting. With the 
tablet it may well be you’re adding in another tablet so you’re 
now on thirteen tablets a day and you have to remember to 
take the tablet. And not doing anything, in actual fact, they 
do maintain, they are, they may well be increasing the risk 
of developing complications. So it’s about saying, ‘well look, 
this is where your diabetes is at the moment, this is where 
ideally your diabetes needs to be to help to reduce that risk, 
these are the options that you can have, what do you want 
to do?’ There are sometimes groups that will just say, I don’t 
know. Tell me, and I’ll do whatever you say.’ There are some 
people that will choose to not do any intervention, but to 
actually take their chances and they will say to you ‘I’ll take 
my chance. You know, if I have a heart attack, I have a heart 
attack.’ And then there are some people who will say, ‘well, 
what would you recommend?’ So, if you do give them all three 
choices, […] quite often people will decide themselves. And 
that’s fine. You know. And sometimes, you know, they get to 
the target, other times they don’t. If, for example, somebody 
chose, so if in actual fact you really know that their diabetes 
would be ideally managed with insulin, but they make any of 
their other two choices, what you need to do then is ensure 
that you’re following them up at regular intervals. So that if 
INVOLVEMENT, SHARED DECISION-MAKING AND MEDICINES 38
EX
A
M
PL
E 
2
their diabetes control deteriorates further, you know, you are 
able to step in and say, ‘well, should we review your plan?’ and 
go from there really. 
It was an example of giving someone some options which, 
in a sense, were difficult to make, I think. […] And my 
perception with this particular patient, but equally with other 
patients in a similar situation, is that they can move on when 
they reflect on the fact that, at the end of the day, it’s their 
condition and they’re in the most powerful position to  
change things. 
The promotion of patient self-management thus entails a 
systematic re-thinking, and ‘re-tooling’, of healthcare systems 
and relationships and this makes it a very substantial 
practical and organisational challenge. At its heart though 
is a change in the consciousness of both professionals and 
patients, and in their habitual scripts. And, even when this 
shift of orientation is successfully accomplished, the new 
scripts are far from problem free but include significant 
burdens and dilemmas for both patients and professionals.
COMPONENT 4. BEING RESPONSIVE TO PATIENT 
PERSPECTIVES
When professionals fully attend to the perspectives of 
patients they do not just encounter ‘information’ – accounts 
of patients beliefs or opinions about things – but the whole 
of the ‘first person’ experience and point of view; what 
is sometimes called the patient’s ‘lifeworld’. This means 
encountering and responding to the emotional dimension 
of patients’ lives and the strong emotions that inevitably 
accompany many stages in the illness trajectory:
And people can get very, psychologically people can get, 
feel that they’ve failed. If you want to introduce a tablet into 
somebody’s diabetes management, if you say that, they feel 
they failed. You know, […] and it can be quite devastating 
for them if they realise that they’ve got this condition where 
they need to take medication. So […] at the very beginning 
you need to explain to them that diabetes is mainly 
managed through diet and lifestyle where possible. But, 
because the condition changes over time, we will probably 
need to introduce some form of medication. 
You’ve got, you know, the patient regret as well in it, ‘if only 
I had done, if only my control had been better’ you know, 
‘I’ve done this to myself ’. You know, not everybody because 
some people still just say, ‘oh well, you know, it isn’t my 
fault’, you know, ‘nobody told me about, the complications of 
diabetes.’ But, for some people there is this awful guilt […] 
and fear, really, of what is happening and what will happen. 
Particularly in people in renal failure and, you know, and 
people whose eyesight is deteriorating, it can be very scary 
at that stage. 
So of course then years down the line again, […] it may 
well be, because diabetes is a progressive condition and it’s 
a chronic condition and they say that in type-2 diabetes 
sixty percent of people will need insulin, we are... you know, 
six years after diabetes, commonly recommending using an 
injection to manage diabetes and at that stage, that’s the 
hardest part for somebody. That and the development of a 
complication is really very very hard and the biggest piece 
of my work is about supporting people make the decision 
to use insulin, that’s the majority of the work that I do there. 
And that is because […] they feel they failed, which isn’t 
true, and secondly they’re really fearful of needles and there’s 
huge myths around insulin, and, what […] can happen if 
you’re taking insulin. And I think, because of the age group, 
a lot of people look to their parents and their parents used 
insulin basically just before they died, or just before they had 
their foot amputated. So they have all of those feelings that 
they come with. 
It is evident that supporting self-management involves 
attending to the whole person and cannot be understood 
as simply a rational-technical process. The support that is 
offered may include information exchange and use decision 
tools etc. but it is also, at the same time, emotional support 
or care. Accompanying and helping someone on an illness 
journey calls for dispositions which reach into the core of 
carers and which, sometimes, for very good reasons, are 
not always available from professionals. Those professionals 
who are helping to foster and support self-management 
face a range of difficult balancing acts and dilemmas and 
one thread running through these is the need to balance 
the encouragement of independence with the need to be 
ready to offer emotional support when it is needed. Some 
of the balancing acts faced by professionals might be seen 
as largely pragmatic or ‘tactical’ questions – for example, 
when to support short-term decisions from patients, even 
where these might be seen as sub-optimal or are against 
guidelines, in order to build a longer-term relationship 
founded on the values of self-management: 
That’s when the dilemma comes in. Because if, you know, 
this guy may well now be heading to nine months, twelve 
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months from when he was first referred in. But the reason 
why we haven’t stepped in quickly is because he’s declined 
the treatment. He’s declined whatever treatment we’ve got. 
And, you know, the guidelines will say to you, well, you need 
to do this, you need to do that, you need to do the other, and 
in theory, it shouldn’t be twelve months down the line where 
we haven’t optimised his control. But we are, because we’ve 
needed to go through that rapport with him and he needs 
to engage in that treatment before we can give it to him. So 
there’s a dilemma there. 
Well, it may be that you... the optimum insulin regimen 
to achieve the best glycaemic control just wouldn’t be 
acceptable to a person. So you might suggest a certain 
insulin regimen, but actually the patient is not... is going to go 
away and only give […] one injection a day. So you might 
then have to decide with the patient, what is it they’re willing 
to do! And then in some ways, that’s the optimum for that 
moment and that time. 
Other similar, but sometimes more fundamental, dilemmas 
reported by professionals include: the question of how far 
to try and change the scripts of interactions away from 
a traditional ‘expert-led’ model when the patient does 
not want this change to happen and where other aspects 
of the care environment are reinforcing the traditional 
model; and how far and when to try and persuade patients  
about the ‘best option’ or rather accept and welcome the 
patient’s preferences:
A patient might come and they’ll say, ‘Well, look, I’m just here 
to do whatever you tell me!’ and as far as I’m concerned, 
that’s the patient’s choice and I will give them the options 
and then they can maybe make a choice, but we might, you 
know? I mean, I might be that sort of patient. I just want 
to be told what to do, so I can do it and get on with my 
life – that sort of thing. You know, I can see how someone 
can make that choice, […] so I think that we have to be 
responsive to the different approaches that patients take.
I think you do try and put some gentle pressure, if you feel 
that there is a... a clinical danger for the patient, there’s 
a danger for the patient. So, it may be around, you have 
somebody with, say, Type 1 diabetes, if they don’t take their 
insulin at all, you know, the possible scenario is death! So, 
I mean, you want to ensure that the patient, you know, 
remains alive! So, the pressure might be, ‘OK, this is how the 
insulin works, this is what each one does, this is the insulin 
that if you don’t take you have a risk of being seriously 
unwell […] you know? So this is what I would say, I would 
say to you, ‘never... never miss this particular insulin.’ So I 
would put that sort of pressure on somebody, yes, that sort 
of pressure saying, ‘this is, this insulin keeps you alive. This 
other insulin is for your food, so if you miss a meal or if you 
don’t give it, your blood sugars will go high, and you won’t 
feel very well, but…’
Achieving the right balance here is difficult but particular 
concerns were expressed about any notion of ‘choice’ 
that simply transfers the traditional responsibility of the 
professional to the patient and fails to represent the need 
for, and importance of, the professional’s contribution to, 
and accountability for, clinical decision-making:
So there’s this shift around to how do we support the patient 
[…] in this, so if you’re looking at it from the best point of 
view, you would say, well, how do we support the patient in 
their self-management? And the worst point of view is well 
that’s the patient’s decision, and they decided not to do 
anything about that and they died! You know? So […] what I 
really would be careful with, is that by shifting responsibility - 
maybe that’s not the right word! – but by collaborating, what 
you do then is blame the patient for not doing things.
The patients are making the decisions, because equally 
they’re [the clinicians] making the decisions, you know, maybe 
even, maybe not equally, maybe it’s something like eighty sort 
of twenty, and the clinician is twenty percent and the patient 
is eighty percent because, after all, they’re the ones who 
are going to have to go away and decide to take the tablet, 
etc. So […] if the patient is making the decisions with the 
support of the clinician, then they’re more likely to do it.
I think that’s really important, that the clinician’s agenda is 
equally important as the patient’s agenda and vice versa. It’s 
not just about one or the other. 
It is evident that supporting self-management is no easy 
task. It necessarily entails working with very difficult 
emotions and, simultaneously, calls for considerable 
professional judgements in managing the inherent balancing 
acts and dilemmas. Although this can be very satisfying 
work it was also frequently referred to as ‘exhausting’.
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Example 3 
SHARED DECISION-MAKING IN CARE PLANNING FOR MENTAL 
HEALTH CRISES
The work reflected on in this example is a structured 
approach to collaborative planning developed with 
adults who experience recurring psychotic episodes. This 
approach includes an exploratory agenda-setting discussion 
and a subsequent shared decision-making meeting which 
formalises agreed care plans for future episodes in writing. 
This approach has been tried and tested (albeit in a 
research context) and is currently being ‘rolled out’ to 
another group of patients with less severe conditions. This 
is a multi-professional approach and the discussion here 
draws upon conversations and interviews with medical 
consultants and other staff who have been closely involved 
with this work.
COMPONENT 5. JOINT AGENDA-SETTING
There is, of course, no sharp distinction between agenda-
setting and decision-making. Constructing an agenda 
involves making a lot of ‘decisions’ and a critical issue 
for patient involvement policies and practices is at what 
stage, and how far, patients are involved in determining 
what happens and what gets considered in healthcare 
encounters long before any final treatment decisions 
are made. But there is a useful commonsense distinction 
between the processes of exploring and discussing the 
‘menu’ of care and treatment possibilities and the processes 
of ‘closing off ’ the options by coming to an agreement 
about what should happen. The development of a ‘joint 
crisis plan’ separates these two phases out by having two 
separate meetings. Crucially the first meeting is not run by, 
or inclusive of, the clinical team but supported by a trained 
facilitator, who is normally a mental health nurse but could 
potentially be a suitably experienced lay facilitator :
A facilitator, who’s independent of the clinical team […] 
will meet with the patient when the patient has recovered 
from their previous episode, and discuss with them the kinds 
of things that could go on such a plan, so there is a menu 
of items. They would include things like, what their current 
treatment is, what their current medication is, who they’re 
seeing, if they know the consultant, their care co-ordinator, 
or case manager. Then it might include things like, what are 
the early signs, the first signs of relapse? What […] has 
been effective in the past in averting a full relapse during 
that sort of phase, what has been unhelpful? Might include 
medication, might include calling somebody to be with the 
patient, or somebody to talk to the patient. 
A broad range of issues can be covered in the plan. These 
include issues that are both central, and less central, to the 
clinical agenda, but they will all be things that matter to the 
patient and for that reason are central to the provision of 
appropriate care and support:
It’s up to the patient what goes in the crisis plan, it’s not 
prescribed. The menu offers them the choices and the 
possibilities, they can put other things in that haven’t 
occurred to us in the past.
Whether they’d want somebody contacted who would make 
sure that their flat was secure, say, or arrangements had 
been made for children or pets, or whatever, that kind of stuff. 
When does the patient think an admission is appropriate? 
Admission to hospital for patients with a psychosis is a very 
fraught thing usually, because the patient often doesn’t 
believe there’s anything wrong and they don’t believe they 
need to go into hospital. So, to be able to reflect on this and 
to think about it and plan when the patient is able to make 
a judgement about the appropriateness of hospitalisation is 
a very... well, it’s ethically a useful approach and in practice 
we’ve got evidence that it does make a difference. 
‘What should we do when… you start to behave in a 
threatening way...?’ I mean, because people have things that 
set them off or will help to calm them down, and those are 
very, very kind of individual.
There are significant challenges and obstacles to 
implementing this kind of structured agenda-setting 
exercise in this context, many of which have relevance for 
other services also. For example, it involves a readiness 
on the part of professionals to find the time and other 
resources needed to properly attend to the emerging 
patient agenda (because it would obviously be counter-
productive to have agenda eliciting meetings which are 
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not followed up); in some instances professionals may be 
sceptical about the capacity of patients to contribute, and 
some patients may also be sceptical about the possibility 
and point of doing so:
How are we going to find time to do all of this, to have a 
discussion with the patient, and then to have this joint crisis 
plan?! And that’s complicated to get all of those people 
together, you know, at the one time, and for the patient to 
turn up as well. 
There may be some staff, clinical staff who are just very 
sceptical that such a thing would be meaningful […], that 
you should pay so much attention to what the patient says, 
you know, when they’re clearly very psychotic and don’t 
know what’s in their best interests, that’s going to be... it’s not 
that common, but, you know, it sometimes arises… 
Basically patients with a history of mental illness are very 
... are generally - especially those who have been admitted 
to hospital under section - a bit mistrustful of services. They 
see them as kind of authoritarian people who can make you 
do things that they won’t want to do. […] So to persuade a 
patient that actually, look, this really is an opportunity for you 
to have some... a voice in your treatment, may be difficult for 
some. You know, some are so suspicious, so disbelieving that 
this could ever happen to them, that they’re not prepared  
to engage. 
Here, as in all the other cases, there are some patients who 
do not want to, or see it as their job, to take a share of 
the planning. But for some people, and in some respects, 
this reluctance can be seen as an understandable response 
to a lack of relevant experience. The strength of the 
contribution that patients can make is to some extent a 
product of the depth and breadth of their experience:
It’s difficult to get people […] to imagine risks, if they’ve 
had no experience of, […] or relatively little experience of 
being unwell, if you like.
Once the patient has had a couple of years of treatment, 
and they’ve probably tried different things, they’ve got quite 
a lot of experience, as it were, of what works and doesn’t 
work. And it’s much easier for them to, for us to have a 
discussion, because if you’re having a discussion early on, it’s, 
‘what can I say?’ They... the range of options may be just a 
little overwhelming and difficult to make sense of. 
Nonetheless, although lack of relevant patient experience 
can circumscribe the scope of the contribution that 
patients can make to agenda-setting, there are many 
aspects of agenda-setting (such as potential social support 
needs or the personal ‘pet hates’ about professional 
behaviour) which are less dependent on extended 
experience of conditions or treatment and which matter 
just as much if services are to be responsive to patients.
COMPONENT 6. JOINT DECISION-MAKING
Following the agenda-setting meeting there is a decision-
making meeting – the joint crisis planning meeting. Here 
the goal is to bring together the patient (along with the 
independent facilitator and possibly an advocate/friend)  
and the clinical team and to come to an agreement about 
what should happen in the event of another episode 
needing care:
The [...] patient is invited to bring a friend, relative or an 
advocate with them. And the care co-ordinator, and the clinical 
team, we want a senior psychiatrist there, the consultant 
preferably, or a senior psychiatrist – usually, the consultant. 
The care co-ordinator will be there, and we then have the 
facilitator, the independent facilitator, whose role it is to ensure 
that the patient’s voice is heard; that the patient is happy 
with what is going to go in the plan. The patient has the last 
word about what goes in the plan. If the patient doesn’t want 
something to go in the plan, it won’t go in the plan. 
The aim of the meeting is to find a negotiated agreement 
about what should go in the plan. This may involve some 
compromise on the part of the clinical team, it may involve 
some compromise on the part of the patient. In the vast 
majority of cases, such an agreement can be reached. 
Patients in some way self-select themselves, as people who 
want to have a greater say in their treatment, who want to 
have the opportunity to influence the clinical team. 
The agreement aims to cover all of the kinds of issues 
that have been raised in the agenda setting meeting - for 
example, how to interpret and respond to a relapse, 
preferred treatment options, treatment refusals, conditions 
for hospitalisation, who to inform and involve for personal 
and social support and what that includes. The clinical 
team may not find it possible to secure agreement to their 
own ‘first choice’ treatment but that is simply part of the 
compromise and agreement process. Sometimes, of course, 
full agreement will not be achieved, but the patient’s 
preferences can still carry independent force:
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The psychiatrist might think that a particular medication 
is the most appropriate, the most effective, or best. But 
the patient may have... may not be willing to have that 
medication, it may be they’ve had the medication in the 
past, they haven’t found it particularly helpful or they don’t 
like the side effects. And so [...] they’ll say, ‘Well, I don’t want 
that medication, but, you know, what other medications 
might there be?’ And so there might be an agreement on 
another medication, which may not be the first choice 
medication, but which is satisfactory from the point of view 
of the clinical team, and acceptable to the patient. 
Occasionally, they cannot agree, in which case […] it’s not a 
joint crisis plan, it’s what we would call a crisis card. But any 
patient can state their written preferences. […] Refusals 
have to be taken into account now, they have legal force 
under the Mental Capacity Act. 
The process described here thus refers to a structured 
and formalised application of a ‘shared decision-making’ 
approach (an idea which can sometimes be used in a 
more extended, diffused or even metaphorical sense). It 
‘operationalises’ shared decision-making in the form of the 
two systematically organised meetings and in the form of 
the written ‘plan’ which records the agreed decisions and 
which is held by the patient and others:
Usually the clinical team, obviously, has a copy. The patient 
will usually choose to carry a copy on their person. Then 
they will decide whether they want the GP to have a copy 
and usually the GP has a copy. Usually a relative or friend 
will have a copy, and then it’s up to them, you know, if they 
then have other people; like […] if they’re living in some 
supported accommodation, then they’ll want the manager 
of that place to have a copy. It’s […] up to them. There’s a 
whole range of possibilities.
The professionals involved in this work report (based on 
research evidence and first hand experience) substantial 
benefits in relation to major clinical indicators, and more 
subjective and qualitative factors. However the challenges 
and dilemmas should not be underestimated. As with the 
agenda-setting element, noted above, the first challenge is 
working out when this broad approach is suitable. It is not 
simply that some patients may express a preference for not 
wanting to engage but that there are circumstances where 
professionals have to make a judgement about whether 
this kind of partnership working is feasible or in the best 
interests of patients. Sometimes people are clearly too 
unwell; on other occasions a more complex and balanced 
judgement may be called for :
Where somebody is acutely psychotic, particularly in the 
early stages, they might be generally very anxious and 
suspicious, and, don’t understand that they’re unwell. 
It’s quite a delicate, fragile situation in terms of trying to 
work with somebody who’s acutely unwell like that. […] So 
it does feel more appropriate to just try and persuade them 
to take something that [...] will relieve the situation, and then 
talk about it at a later point in more detail. 
Once you start discussing options, you start having... 
inevitably having to discuss levels of certainty about different 
things. And once you start raising the prospect of some 
uncertainty about this, ‘well, this... this may help, or it may... or 
it may not’, for instance! You know, ‘or it may help two thirds 
of people... it might help you...’, then some people do not 
respond to that so well. I find that quite anxiety provoking. 
I mean, I think the power of placebo sometimes is about 
being able to say to somebody, you know, ‘this will help you.’ 
And [...] some people do seem to be looking for that.
Properly executed, shared decision-making changes some 
of the default assumptions about healthcare relationships 
and responsibilities. For example, it means that the problem 
of ‘adherence’ becomes a problem for the professionals and 
the health system and is not just a problem about patient 
behaviours – will professionals ‘follow through’ on the 
agreed plans and what are the possible problems if they do 
not? It also raises potential problems for the accountability 
of professionals for risks and costs, when they are only 
one party to the decision and may have good reason 
to compromise to accommodate patient preferences. 
In other words, and once again, very significant practical, 
organisational and ethical challenges are inherent in shared 
decision-making approaches:
The more you allow patients to voice their preferences, the 
more you confront the question of: if the patient strongly 
prefers a treatment which you know is not very effective, 
and rejects a treatment which you know is very effective, 
and you go along with that, and something terrible happens 
– the patient commits suicide – how will your professional 
body, the General Medical Council, how will the coroner view 
your behaviour as a clinician in this respect? […] If we’re 
serious about patient participation and this shared decision-
making, we really need to look through the consequences [...] 
at the level of regulatory bodies and legal bodies. 
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In addition to the demonstrated clinical benefits, the 
professionals interviewed were very clear that the joint 
crisis planning work had broader benefits for patients and 
professionals and that the general approach had substantial 
relevance to all other aspects of their work (and healthcare 
generally). The benefits of starting from, and taking seriously, 
the values and preferences of patients can be derived 
even in cases were the conditions for full formal joint 
decision-making are not met (for example, because of lack 
of capacity, or inability to agree). Even within the context 
of compulsory treatment, there are still some meaningful 
and important choices that can be offered to patients 
(for example, about administration of medicines – such 
as depot injections versus supervised oral medication). 
More generally, being able to participate in one’s own 
care decisions enhances the experience of care and the 
likelihood of it being effective:
The thing I heard very strongly from patients was that their 
biggest priority was just not wanting to be back in hospital. 
Which is where I now feel more confident about, trying to 
give people choices, but choices that will keep them out 
of hospital! [...] They know they don’t want to be back in 
hospital, but they don’t have the insight about the need for 
treatment, then we... within a legal framework, we give them 
options that will meet their primary desire, which is to stay 
out of hospital! 
Inevitably, in having that discussion, you learn more about 
what […] the patient or the user wants. So, you have a 
better understanding of them. You’re spending the time 
looking at the options with them, and I think that is often 
appreciated, and that helps your therapeutic alliance, your 
working relationship, and whatever you then come up with, 
you’ve got a situation where, if the patient has said, ‘yes, I 
would prefer that one’, […] then they’re more motivated to 
stick with it.
You know, that we might think something is a good idea 
for them but, I mean you can offer people things until 
you’re kind of blue in the face and if you haven’t found out 
what’s important to them or what the barriers are to their 
accepting it, you know, then you’re always going to be, yeah, 
wasting your time really. 
Analogous benefits can apply to professionals, including 
improved relationships, a greater sense of efficacy and, in 
some respects, a broader conception of potential roles and 
satisfactions in health care:
I should have said that one of the values of the joint crisis 
plan is not just the information that’s there, which makes 
clear what should happen in a crisis, but the process of 
negotiating it changes the relationship between the patient 
and the clinician; that may be the most important thing, it’s 
that change in the relationship, you know? It is a different 
kind of relationship and there’s more trust on both sides. 
I think it’s largely to do with role models and the way in 
which different professional groups relate to patients, you 
know? One can learn a lot from watching experienced 
nurses, or experienced social workers dealing with patients.  
I’ve learnt a lot from non-medical staff about [...] how to 
deal with patients.
I mean, social workers are better at this really, in that they... 
they start where people are at. You know, they have this kind 
of adage, ‘you start where people are at.’
Because it’s... you know, this essentially makes working with 
people more interesting and more fun, I think, you know? If 
you’re not just, kind of, asking the same kind of symptom 
questions all the time. 
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Example 4 
EXTENDING AND ENRICHING RELATIONSHIPS IN HIV CARE
Healthcare for patients who are HIV positive is, like 
diabetes care, an area which is well known for developing 
and ‘normalising’ innovative approaches and practices. 
As with all the cases discussed here, the crux of 
developing patient involvement practices is re-conceiving 
and changing conventional patterns of relationships 
between professionals and patients. These processes of 
re-conception and reconfiguration are potentially very 
broad ranging and far reaching and relate both to care 
relationships with individual patients and to broader 
relationships within the social field of healthcare. The 
work cited here indicates some of these possibilities and 
draws upon interviews with medical consultants and 
conversations with other related professionals.
COMPONENT 7. RELATIONSHIP BUILDING
Building stronger and richer relationships is very 
demanding, because it entails taking on more open-ended 
commitments; it depends upon paying attention to, and 
being respectful about, relatively ‘small matters’ in clinical 
interactions and having the same regard for the ‘large 
matters’ that extend well beyond the clinical interaction 
in both time and scope. This is evident, for example, from 
the level of concern that can be attached to helping to 
negotiate a medicines regime that is suitable for individual 
adolescent patients and from the level of concern and 
understanding that the same team can show for why some 
of these patients do not take their medicines but still need 
the same quality of attention and care. This point will be 
retuned to shortly. First, there is some degree of choice 
about medicines and this has to be practically negotiated:
Your starting point has to be, you know, what do you think 
you can manage and what can I fit around that? So for most 
adolescents, a once daily regime is usually fairly high on their 
priorities, with a low number of pills and pills that are small. 
I mean, you can’t always create the magic, but, if you don’t 
start out with what they want and then what can I fit to it, 
there is no point. 
We have a box with all the pills in, and I can take the pills 
out, different sizes, and say, ‘well, if you take that... you have 
to take three different medicines to suppress your virus in 
three different ways, otherwise you’ll get resistance’. And 
some of those have been combined, so I can take them out 
and say, ‘well, do you fancy the blue one, you know?’ […] 
And then you line up the baby pills and say, ‘well, you’d have 
to take four of those little ones, plus one of those. Or four of 
those. Or you could just take the two big ones.’ And that’s, 
you know, they can see them, they can feel them.
You have some choice in what you are going to be able to 
take. And particularly things like fitting it in around college 
[…] Unless you’re given that choice and that option, and 
you actually understand the lifestyle of the young person 
that you’re dealing with, there is no point in prescribing 
things at 8 and 8, because they’re not going to be out of 
bed! […] It’s about knowing enough, or the team knowing 
enough about [a] young person’s life to be able to fit the 
medicines within their lives. 
These focussed exchanges about treatment choice are one 
manifestation of respect and mutuality, and a small part of 
the open-ended process of coming to know and forming 
a relationship with patients, which takes time and is an 
endless task:
It’s about getting to know somebody, understanding them, 
making them feel comfortable in the setting which is strange. 
Hopefully winning their confidence, so that, you know, when 
you suggest something to them they trust that. And usually 
it’s, you know, as I say, it’s just a normal process. And because 
there are genuine options. I mean, […] it’s not like we can 
say, you know, medical evidence is completely clear-cut, this 
is what you should do. We can actually say, ‘well, you could 
[do] this you could do that, it’s up… you know, it takes… 
you decide how you want to do it’. 
But once they know the diagnosis, aged sort of around 
between 10 and 12, they know the name, they know it’s 
HIV. And from that point on, we start to see them for a small 
time alone and then their mum or carer comes in to the 
appointment. So that you build a relationship with them. And 
then around 13, 14, when they’re sort of phrase competent, 
I explain where my confidentiality is, you know, what they 
say doesn’t necessarily go out the door unless, obviously, 
you know, it’s something that I need to act upon because 
it’s going to harm them or somebody else. I mean, we never 
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know... we only know a tiny bit of what happens in patients’ 
lives, but at least you get a bit more of a picture. And I think 
being able to have a one-to-one with an adolescent, you 
know, a one-to-one chat on a relatively regular basis does 
help build that picture up of what is going on in their lives, 
but it’s only a tiny bit; you’re forever surprised. You think you 
know somebody and then... oh, my goodness! 
Of course patients may not want to engage with health 
professionals or to cooperate with health systems but that 
does not mean that professionals cannot be flexible and 
imaginative about maintaining some kind of relationship; 
nor, above all, does it mean that professionals cannot make 
an effort to understand patients’ lives, including their social 
and psychological lives. And these exercises in imagination 
and empathy can extend into areas which – from a purely 
biomedical perspective – can be profoundly challenging  
and frustrating:
So some young people who are sick, you know, we’d see 
very frequently, every couple of weeks. But then some 
young people who are doing badly don’t want to engage. 
So they won’t come and then there’ll be a crisis, and then 
they’ll phone up. So that we do lots of sort of open access, 
so they have a way, you know, they can get hold of us. We 
do texts and everything, so people can just, you know, text 
you and tell you that they’re in a crisis moment. […] So 
there is no two-strikes, you know, if you don’t turn up to two 
out-patient appointments. If you don’t turn up to your out-
patient appointment, you’ll be phoned by me or by one of 
the nurses. You will then be texted, you will then be phoned 
again, texted again, and then, you know, as I say, I bug you 
enough and you turn up! And they laugh! 
There’s more to coming to hospital than taking your pills. You 
know, it’s more about being able to have those conversations 
about how do you negotiate relationships, when you have 
HIV and you’ve never had sex? How do you... you know, how 
are you going to disclose to your best friend when you want 
to tell them? You know, [...] so it’s more about... and when 
things go wrong, who are you going to turn to? And are you 
going to have a relationship within health care that means 
that you can come back and take at least your antibiotics 
and your anti-fungals. Or if you get pregnant...! 
So we have a section of the population in clinic who have 
never taken... really taken their pills. But they need looking 
after, even if it is only establishing a relationship with them, 
so that when they do become sick, they have a relationship 
with someone who they will turn to when... you know, for 
palliative care, you know, sadly that is happening, that they 
have somebody who can help them through that as best  
 as is possible. 
[There are some patients who] despite everybody’s best 
efforts, will never get on to medicines and they will die 
from their HIV [...] and it’s utterly tragic and in some ways, 
very frustrating. I don’t think we tend to get frustrated now 
because we’ve seen it enough to sort of understand the very 
complicated... well, not understand but live with the very 
complicated reasons they have for taking those decisions. 
Or not taking those decisions. Or the fact that HIV is such 
a big... it’s such a big beast in the box, that sometimes just 
to, you know, denial [...] is a very protective mechanism, in 
some ways. It can be a very destroying mechanism, but you 
can absolutely understand where they come from, in just not 
wanting to open that box. 
Building relationships thus involves an ability to see things 
from other (non-clinical) vantage points and against longer-
term time-scales. If what matters is the long-term wellbeing 
of patients then health professionals have to try and find 
a balance between their provision of, and advocacy for, 
immediate treatment needs on the one hand and their 
longer-term and deeper ‘availability’ to patients. In an era 
where, for good reasons, cost-effectiveness is never far 
from consciousness and where measures of ‘outputs’ are 
often rather narrow, the widespread implementation of 
such open-ended conceptions of care is not easy:
I think that’s the main thing, that it is very time consuming. 
And I dread somebody coming across and saying, ‘well, 
you’ve put all this time and effort in and let’s see what   
the results are!’
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COMPONENT 8. RE-WORKING RELATIONSHIPS 
AND SYSTEMS
Once the potential open-endedness of professional-patient 
relationships is acknowledged and responded to through 
less restrictive professional ‘scripts’, then more fundamental 
kinds of relationship change become visible and possible. 
Healthcare relationships, and associated health systems can 
be, and are being, re-worked in a variety of ways. Some of 
these changes are already quite widely embedded across 
many areas of healthcare; others are still emerging. For 
example, the idea of multi-professional or inter-professional 
‘team-working’ is widely accepted, as is, increasingly, the 
notion of somehow including patients and lay caregivers 
into constructions of ‘the team’; i.e. there has been a shift 
away from thinking of healthcare as about the professional-
patient dyad and towards the idea of putting in place and 
supporting networks of care relationships. But, as with the 
diabetes example, whilst it is easy to see the advantages 
of more holistic and multi-professional team-working, 
there are logistical challenges created in a context where 
many professionals work in different sectors and in ‘shifts’, 
especially when this complexity is contrasted with the 
importance of ‘continuity of care’ and relationship-building. 
For example:
If you have HIV, to have to go and tell your whole story 
again, it can be very complicated. 
Sometimes you get a situation where it’s almost like, 
overwhelming at the beginning because you, you’re 
potentially talking about drug treatment for the mother for 
their own health, how to deliver the baby, what to feed the 
baby taking treatment. And so sometimes you just say, ‘ok, 
forget, the baby is not even born yet, let’s worry about that 
later on, let’s just think about what you need and at the 
moment your health is such that we would advise you to 
start antiretroviral therapy and we’ll worry about how you 
deliver later on, let’s see what happens with that.’ 
In that clinic setting it’s usually myself and a midwife, the 
same person, the same two people all the time. […] So 
yeah, they do get a continuity of care. Some of them have 
been pregnant before and are old friends, coming back. 
There are also many circumstances where the focus of 
professionals has to extend beyond the individual patient. 
This is because, even in the immediate situation, there 
may be more than one person’s health and wellbeing to 
bear in mind (for example, because of pregnancy, or other 
dependents, or carers) and this can sometimes give rise to 
difficult tensions and dilemmas:
A mother might decide she doesn’t want any treatment 
during her pregnancy, and we would say, ‘well that’s, may be 
ok in regards to your health but it’s not good for your baby 
because it increases the risk of the baby becoming infected 
with HIV.’ All we can do in that setting is try to explore why 
they have, that person has this belief or persuasion. […] You 
can’t make them take a treatment they don’t want. […] 
Now you can’t dictate on how they deliver either. So, they 
have their choices right up to, you know, up to that point. But 
once the baby is born it’s different, the baby has its own right. 
Often they have their own, you know, HIV within the family, 
they have their own children, they have their own issues; they 
come from a sector where unemployment is very high […] 
and therefore there’s a lot of other factors playing on the 
carer’s ability. But a younger child is dependent on the carer 
giving him the medicines. So we work very... very closely with 
parents, carers, in a very supportive role. Although if carers 
won’t engage, you know, we do occasionally have to get social 
services involved to try and sort out exactly what is going on. 
You know, you have to get it right when you decide to start 
a child on medicines, and they... often with HIV, you see, they 
don’t know why they’re taking their medicines early on, so it’s 
even more complicated, but you have to be very... you know, 
with their carer has to take that responsibility. I mean, we’ve 
always thought it was very important, but I think increasingly 
we see the late effects of, you know, teenagers and young 
adults who were born with HIV basically dying because they 
never got onto medicines properly through the whole of their 
childhood and adolescence, and with a treatable virus still.
It is notable that the professional who made this last 
remark reported becoming increasingly ‘assertive’ in 
their approach to carers in an effort to help secure the 
longer-term health and autonomy of the patients who 
were dependent upon them. Finding the right – ethical 
and practical - balance between assertiveness and 
responsiveness depends very much on the case in question 
and can also vary depending upon whether one is dealing 
with a patient or a carer. In addition to a family orientation, 
there is also, of course, a public health dimension that 
enters into the balancing acts that shape policy and day to 
day practice:
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And there’s also the public health of preventing onward 
transmission, so that you need young people to stay 
engaged in services in some way, and if you just make it  
all about, ‘do you take your medicine, or not,’ they’re not 
going to come. 
Enriching relationships is not, therefore, all about finding 
fuller and deeper ways to relate to the health experiences 
and needs of individual patients but may also involve 
challenging patients and carers to be responsive to 
the needs and wants of others. According to these 
professionals, treating someone with respect can involve 
something more than, and different from, being simply 
responsive to them. One of the ways in which this can 
be accomplished is by giving patients roles as ‘people’, 
especially roles in which they are clearly not passive or 
subservient. For example: teaching medical students about 
what counts as being a good communicator and doctor:
One of my savvier older teenagers… [...] I said, ‘would    
you mind spending 15 or 20 minutes explaining to 
him [a medical student] what you think makes a good 
communicator in a doctor?’ 
It’s good for them to have somebody listen to them and, you 
know, to feel that... I would say to him, ‘you don’t have to do 
it, but while you’re waiting to get your pills, will you talk to 
the medical student? They’re learning, this is our opportunity, 
you and I to teach them to be a better doctor’.
If you ask adolescents what they want, they want someone 
who knows their stuff. I mean, they know if somebody is 
lying and doesn’t know the answer […] They want someone 
who’s interested. They want someone who will maintain their 
confidentiality, and they want somebody who is interested in 
them as a person. 
It’s just better as an educational experience to hear it 
from a young person who is a patient, who has really been 
through the mill and can tell you really exactly what it’s 
like to be not told about what’s going on for days on end 
in hospital; to be ignored when they’re in pain; for people 
to talk over the top of them; for people to be basically 
patronising, you know? You hear it from them, and they 
usually put it pretty straight! 
Encounters such as this, i.e. non-clinical encounters in which 
professionals and patients meet as people, can help to 
dislodge habitual assumptions and scripts. This advantage 
also arises, for example, from experience of dealing with 
people in a range of other contexts, for example, in 
working with potential ‘research subjects’ where their status 
as independent and autonomous people is so much more 
clearly embedded in understandings:
So research is actually a very good place to start in terms 
of involving people in their care because it’s a real, it’s a real, 
it’s a formal contract actually. […] This is what it will involve, 
maybe you’re gonna take a new drug, or you’ll take a drug 
in a different dose or whatever. And, this may be harmful, it 
may be beneficial, we don’t know until we’ve tried it and it’s 
your choice as to whether you take part or not […] and the 
bottom line is whatever you decide is right. I mean, if you 
decide you don’t want to take part that’s fine, we’ll still look 
after you as well  as we can, you know, and be very clear 
about that and meaning it. 
Patients can also be active as people, and can be 
encouraged by systems to be so, in more strategic and 
collective ways by working both within and ‘against’ services 
– by helping to inform and devise guidelines, in setting up 
peer support systems, or more generally in being involved 
in the planning, evaluation and/or challenging of services:
There are networks, there are NGOs and so forth, there are 
communities, organisations for people with HIV including 
women’s organisations, black, African organisations and 
so forth and we do... they’re offered, patients when they 
first come will be told about these so they can link in with 
them. Then there’s all the information so there are patient 
information sheets on all the drugs, there’s booklets for 
pregnant women about, you know, the issues in pregnancies, 
[…] which are available. […] They can be pointed to or they 
would get from other resources and stuff from the Internet 
as well. 
HIV, it’s always been a kind of an area where patients have 
been very proactive […] probably always but, you know, as 
therapy started to become available, it was very much a 
case of, you know, ‘have you read this paper?’ Organisations 
sort of set themselves up and, you know, they almost 
challenged patients to go into their doctor’s and say, ‘have 
you read the latest, report?’
HYPNET is the HIV Young Persons’ Network, so it’s a mixture 
of healthcare providers in the voluntary sector with this 
Youth Committee that’s being set up. And we meet four 
times a year […] primarily to look at best practice in the 
transitional care of adolescents with HIV from paediatric to 
adult services.
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The other guidance that we’re writing is this adherence 
guidance. […] And it’s basically asking young people at 
different ages of adolescence, what they thought was 
helpful, and what did they think wouldn’t be helpful, in 
terms of helping them to take medication. 
We’ve set up quite a lot of peer support. So the other idea 
with medicines and HIV is that if you had a peer mentor, 
or attended a... […] there are other agencies called things 
like Body and Soul, and Teen Spirit. So that if you attended a 
support group that might help you with your medication.  
Or if you hadn’t tried... you know, you ought to try... we 
tried to set up a buddy system, so that if you’re a younger 
teenager and you were buddied up with an older teenager, 
would  that help you? 
There are well know tensions around how far patient 
groups can work within professional service contexts or 
how far they should define themselves as being, in some 
respects, ‘combative’ with professionally organised services, 
but these two positions are not necessarily exclusive. 
Professionals emphasise how much there is to be gained 
from meeting ‘service users’ outside of normal clinical 
encounters and in spaces that are seen as more ‘neutral’ 
and ‘equal’, whether these are professionally organised fora 
or ones organised by service user movements and bodies. 
These broader social and professional encounters enable 
professionals to get a feel for patient perspectives in new 
ways and – most importantly – enable services to be 
shaped by those who are subject to them. For this reason 
the collective involvement of patients in their care is an 
important support and complement to individual patient 
involvement. Of course, there are also associated worries 
about ‘representation’ and the fact that some voices will 
get heard and not others, i.e. that variations in access 
or involvement, or wider health inequalities, will not be 
addressed, and may be reinforced, by these initiatives:
So you’d get one turning up and not the other one turning 
up, because their lives are very busy and there’s a lot of 
other stuff going on. And we all went bowling as a clinic and 
we took them, you know, but of course the really organised 
girls turned up, you know? And that’s the same... the same 
people turn up to the sort of voluntary sector and peer 
support, and the same people do... there was a chief of a 
youth committee where they will be able to influence policy, 
practice, commissioning... but it will be the same group. 
This example, like the others, indicates the diverse and 
complex balancing acts and rich forms of engagement 
practised by professionals who care about, and seek to 
enact, patient involvement. The examples, taken together, 
and the discussion of the practical and ethical dilemmas 
embedded within (and across) the eight components 
discussed, hopefully provide a ‘feel’ for the challenge of 
strengthening involvement practices more widely. But they 
also provide a relatively concrete and vivid sense of the 
‘practical wisdom’ needed by professionals, and exercised 
by these groups of professionals, and why this clearly 
transcends (although obviously encompasses) technical 
competence relating either to medicines knowledge or 
‘communication skills’.
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Appendix 2
A BRIEF SUMMARY OF THE MAIN PHILOSOPHICAL AND ETHICAL ISSUES 
RAISED BY INDIVIDUAL PATIENT INVOLVEMENT IN DECISIONS ABOUT 
THEIR OWN CARE, OR ‘SHARED DECISION-MAKING’ IN HEALTHCARE. 
This appendix identifies some legitimate concerns about 
aspects of patient involvement policies. It is not intended 
to undermine the importance of patient involvement nor 
the justification normally offered for it. The concerns are 
identified in a simplified summary form, but many of the 
issues raised are discussed in more detail in this discussion 
paper or in the other project papers that informed it (and 
the references these cite). 
The standard justification for patient involvement in      
care decisions:
Paying attention to, and taking note of, patient perspectives 
(a) respects the autonomy of patients, (b) improves 
decision quality – because patient preferences are vital to 
determining what counts as the best treatment (including 
no treatment), and (c) enhances ongoing effectiveness – 
because it provides ‘informed adherence’ or ‘concordance’. 
Shared decision-making thus allows clinical expertise and 
patient values and preferences to be optimally combined.
Some significant complications related to the standard 
justification of patient involvement:
  What counts as a suitably autonomous patient or, more 
specifically, as the relevant autonomous preferences of a 
patient are not always easy to determine.
  Eliciting the values and preferences of patients is not 
straightforward - for example, even when articulated, 
an individual’s apparently autonomous values and 
preferences are not always internally coherent and 
sustained, therefore the problem of how to identify the 
relevant preferences remain.
  There is a dilemma about how best to handle an 
apparently autonomous preference not to be involved 
(in various respects) in treatment decisions.
  Involving patients in decisions and attempting to elicit 
patient preferences may be burdensome for the patient 
and may be judged by some, at least on occasions, 
to threaten other important dimensions of the 
professional-patient relationship – for example, trust in 
clinicians, and capacity for clinicians to offer emotional 
support and protection.
  Patient involvement in treatment decisions may have 
to be balanced against, or circumscribed by, other 
considerations. For example: (a) professionals will often 
want and need to retain a high level of accountability 
for the decisions that they are party to and this will 
limit the option sets and choices they are prepared 
to embrace; and (b) treatment choices do not solely 
effect the patient involved in them but have resource 
implications and may also have other impacts on 
the public sphere including public health; i.e. broader 
conceptions of decision quality and effectiveness may 
apply than those implicit in the standard justification.
Other significant complications associated with models of 
shared decision-making:
The various models of shared decision-making, both in the 
abstract and in their enactment, necessarily embody sets of 
assumptions that can be questioned; for example:
  It is by no means obvious that the perspectives of 
clinicians and patients can always be unproblematically 
combined – nor are the practical processes or 
‘choreography’ of joint deliberation or negotiation easy 
to specify. And, related to these concerns, there are 
important debates to be had about what ultimately 
‘matters’ in shared decision-making. For example, is 
what matters that decisions are ‘co-made’ or that they 
are ‘co-owned’?
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  The emphasis sometimes placed upon the ‘neutral’ 
presentation of options by professionals is open to 
critique; it is difficult to see how professionals can 
avoid their own values and preferences framing the 
presentation of option sets.
  More broadly, the emphasis sometimes placed 
upon the notion that professionals bring ‘evidence-
based knowledge’ and that patients bring ‘values and 
preferences’ to the shared decision-making process 
can be questioned. Both parties are likely to bring both 
relevant knowledge and values. Nor is it clear that it 
is always, or necessarily, a bad thing for professionals 
to bring their own values and preferences into shared 
deliberation (and indeed some shared decision-making 
models embrace this).
  The expectations built into some practical approaches 
to shared decision-making may have important equity 
implications. For example, some patients, or groups of 
patients, may be alienated, or relatively disadvantaged, 
by specific models and styles of professional-patient 
communication aimed at involvement (or, for example, 
by the levels of literacy assumed by some decision aids).
  There will sometimes be tensions between shared 
decision-making at the individual level (the standard 
case of a professional and patient working together) 
and patient involvement at a collective level (for 
example, service users and providers working together 
to help define the purposes of services, pathways 
of care and suitable option sets). There are good 
reasons to suppose that, at least some of the time, the 
collective deliberated perspectives of the larger group 
of stakeholders could legitimately restrict the scope of 
choice of individual patients.
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ABOUT            
THE ROYAL PHARMACEUTICAL SOCIETY
The Royal Pharmaceutical Society is the dedicated 
professional body for pharmacists and pharmacy in England, 
Scotland and Wales providing leadership, support and 
development to our members. 
We ensure the voice of the profession is heard and actively 
promoted in the development and delivery of healthcare 
policy and work to raise the profile of the profession. We 
are the only body which represents all sectors of pharmacy 
in Great Britain.
Our mission is to promote and represent the professional 
interests of our members, supporting the profession to 
achieve our shared vision for the future. We are committed 
to supporting and empowering our members to make a 
real difference to improving health outcomes for patients.’
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